smiles code,active ingredient,salt,relation,assay value,target disease,protein target,treatment concentration,treatment unit,exposure time (h),measurement,type,model type,description,dataset,REFERENCE_ID,ASSAY_TYPE,ASSAY_ORGANISM,ASSAY_STRAIN,TARGET_TYPE,SRC_ID,ASSAY_SOURCE,UPPER_VALUE,SD_MINUS,SD_PLUS,ACTIVITY_COMMENT
CS(=O)(=O)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,CS(=O)(=O)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,0.0597,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
O=C(NCCc1cnc[nH]1)c1ccc(-c2ccccc2)cc1,O=C(NCCc1cnc[nH]1)c1ccc(-c2ccccc2)cc1,.,= ,0.3055,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CCN(c1ccccc1)S(=O)(=O)c1ccc(Cl)c(NC(=O)CN(C)C2CCN(C)CC2)c1,CCN(c1ccccc1)S(=O)(=O)c1ccc(Cl)c(NC(=O)CN(C)C2CCN(C)CC2)c1,.,= ,51.48,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
CCN(c1ccccc1)S(=O)(=O)c1ccc(Cl)c(NC(=O)CN(C)C2CCN(C)CC2)c1,CCN(c1ccccc1)S(=O)(=O)c1ccc(Cl)c(NC(=O)CN(C)C2CCN(C)CC2)c1,.,= ,0.5940000000000001,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CCN(c1ccccc1)S(=O)(=O)c1ccc(Cl)c(NC(=O)CN(C)C2CCN(C)CC2)c1,CCN(c1ccccc1)S(=O)(=O)c1ccc(Cl)c(NC(=O)CN(C)C2CCN(C)CC2)c1,.,= ,54.13,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
CCN(c1ccccc1)S(=O)(=O)c1ccc(Cl)c(NC(=O)CN(C)C2CCN(C)CC2)c1,CCN(c1ccccc1)S(=O)(=O)c1ccc(Cl)c(NC(=O)CN(C)C2CCN(C)CC2)c1,.,= ,5.43,T.b. rhodesiense,,,uM,,IC50,In Vitro,,HAT in Vitro,set10,1.0,F,T.b. rhodesiense,ATCC 30027,ORGANISM,14.0,HEOS,,,,
Cl.OC(COc1ccc2cc(Br)ccc2c1)Cn1ccnc1,OC(COc1ccc2cc(Br)ccc2c1)Cn1ccnc1,Cl,= ,,T. cruzi,,,%,,% inhibition,In Vivo,,"Chagas in vivo at 20 mg/kg, 5 adm days",set10,1.0,F,T. cruzi,Tulahuen Swiss po,ORGANISM,14.0,HEOS,,,,
Cl.OC(COc1ccc2cc(Br)ccc2c1)Cn1ccnc1,OC(COc1ccc2cc(Br)ccc2c1)Cn1ccnc1,Cl,= ,0.193,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
Cl.OC(COc1ccc2cc(Br)ccc2c1)Cn1ccnc1,OC(COc1ccc2cc(Br)ccc2c1)Cn1ccnc1,Cl,= ,65.88,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
Cl.OC(COc1ccc2cc(Br)ccc2c1)Cn1ccnc1,OC(COc1ccc2cc(Br)ccc2c1)Cn1ccnc1,Cl,= ,,L. donovani,,,%,,% inhibition,In Vitro,,Leish macro in vitro at 10 uM,set10,1.0,F,L. donovani,MHOM/ET/67/L82,ORGANISM,14.0,HEOS,,,,
Cl.OC(COc1ccc2cc(Br)ccc2c1)Cn1ccnc1,OC(COc1ccc2cc(Br)ccc2c1)Cn1ccnc1,Cl,= ,,L. donovani,,,%,,% inhibition,In Vitro,,Leish macro in vitro at 10 uM,set10,1.0,F,L. donovani,MHOM/ET/67/L82,ORGANISM,14.0,HEOS,,,,
Cl.OC(COc1ccc2cc(Br)ccc2c1)Cn1ccnc1,OC(COc1ccc2cc(Br)ccc2c1)Cn1ccnc1,Cl,= ,0.03,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
Cl.OC(COc1ccc2cc(Br)ccc2c1)Cn1ccnc1,OC(COc1ccc2cc(Br)ccc2c1)Cn1ccnc1,Cl,= ,0.7,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10,1.0,A,CYP3A4,unknown,ORGANISM,14.0,HEOS,,,,
O=c1c2ccccc2nc(-c2ccc(-c3ccccc3)cc2)n1Cc1cccnc1,O=c1c2ccccc2nc(-c2ccc(-c3ccccc3)cc2)n1Cc1cccnc1,.,= ,3.4,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 3,ORGANISM,14.0,HEOS,,,,
O=c1c2ccccc2nc(-c2ccc(-c3ccccc3)cc2)n1Cc1cccnc1,O=c1c2ccccc2nc(-c2ccc(-c3ccccc3)cc2)n1Cc1cccnc1,.,= ,0.0255,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
O=c1c2ccccc2nc(-c2ccc(-c3ccccc3)cc2)n1Cc1cccnc1,O=c1c2ccccc2nc(-c2ccc(-c3ccccc3)cc2)n1Cc1cccnc1,.,= ,16.08,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
O=c1c2ccccc2nc(-c2ccc(-c3ccccc3)cc2)n1Cc1cccnc1,O=c1c2ccccc2nc(-c2ccc(-c3ccccc3)cc2)n1Cc1cccnc1,.,= ,0.257,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
O=c1c2ccccc2nc(-c2ccc(-c3ccccc3)cc2)n1Cc1cccnc1,O=c1c2ccccc2nc(-c2ccc(-c3ccccc3)cc2)n1Cc1cccnc1,.,= ,23.28,T.b. rhodesiense,,,uM,,IC50,In Vitro,,HAT in Vitro,set10,1.0,F,T.b. rhodesiense,ATCC 30027,ORGANISM,14.0,HEOS,,,,
O=c1c2ccccc2nc(-c2ccc(-c3ccccc3)cc2)n1Cc1cccnc1,O=c1c2ccccc2nc(-c2ccc(-c3ccccc3)cc2)n1Cc1cccnc1,.,= ,,T. cruzi,,,%,,% inhibition,In Vivo,,"Chagas in vivo at 20 mg/kg, 20 adm days",set10,1.0,F,T. cruzi,Tulahuen Swiss po,ORGANISM,14.0,HEOS,,,,
O=c1c2ccccc2nc(-c2ccc(-c3ccccc3)cc2)n1Cc1cccnc1,O=c1c2ccccc2nc(-c2ccc(-c3ccccc3)cc2)n1Cc1cccnc1,.,= ,19.42,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
O=c1c2ccccc2nc(-c2ccc(-c3ccccc3)cc2)n1Cc1cccnc1,O=c1c2ccccc2nc(-c2ccc(-c3ccccc3)cc2)n1Cc1cccnc1,.,= ,0.026,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
O=c1c2ccccc2nc(-c2ccc(-c3ccccc3)cc2)n1Cc1cccnc1,O=c1c2ccccc2nc(-c2ccc(-c3ccccc3)cc2)n1Cc1cccnc1,.,= ,48.0,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
O=c1c2ccccc2nc(-c2ccc(-c3ccccc3)cc2)n1Cc1cccnc1,O=c1c2ccccc2nc(-c2ccc(-c3ccccc3)cc2)n1Cc1cccnc1,.,= ,36.0,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
O=c1c2ccccc2nc(-c2ccc(-c3ccccc3)cc2)n1Cc1cccnc1,O=c1c2ccccc2nc(-c2ccc(-c3ccccc3)cc2)n1Cc1cccnc1,.,= ,1.6,PBS - pH 6.5,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10,1.0,A,PBS - pH 6.5,NEPH_RT,ORGANISM,14.0,HEOS,,,,
O=c1c2ccccc2nc(-c2ccc(-c3ccccc3)cc2)n1Cc1cccnc1,O=c1c2ccccc2nc(-c2ccc(-c3ccccc3)cc2)n1Cc1cccnc1,.,= ,3.8,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
O=c1c2ccccc2nc(-c2ccc(-c3ccccc3)cc2)n1Cc1cccnc1,O=c1c2ccccc2nc(-c2ccc(-c3ccccc3)cc2)n1Cc1cccnc1,.,= ,0.73,Human,,,none,,EH,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CCOC(=O)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,CCOC(=O)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,.,= ,0.38,Human,,,none,,EH,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CCOC(=O)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,CCOC(=O)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,.,= ,160.0,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CCOC(=O)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,CCOC(=O)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,.,= ,11.0,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CCOC(=O)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,CCOC(=O)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,.,= ,0.003,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CCOC(=O)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,CCOC(=O)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,.,= ,0.4,Blood,,,%,,% remaining,In Vitro,,"Stability, 4 hour",set10,1.0,A,Blood,mouse,ORGANISM,14.0,HEOS,,,,
CCOC(=O)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,CCOC(=O)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,.,= ,1.8,Plasma,,,%,,% remaining,In Vitro,,"Stability, 4 hour",set10,1.0,A,Plasma,mouse,ORGANISM,14.0,HEOS,,,,
CCOC(=O)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,CCOC(=O)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,.,= ,0.037,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CCN(c1ccccc1)S(=O)(=O)c1ccc(NC(=O)CN(C)C2CCN(C)CC2)c(Cl)c1.Cl,CCN(c1ccccc1)S(=O)(=O)c1ccc(NC(=O)CN(C)C2CCN(C)CC2)c(Cl)c1,Cl,= ,1.42,T.b. rhodesiense,,,uM,,IC50,In Vitro,,HAT in Vitro,set10,1.0,F,T.b. rhodesiense,ATCC 30027,ORGANISM,14.0,HEOS,,,,
CCN(c1ccccc1)S(=O)(=O)c1ccc(NC(=O)CN(C)C2CCN(C)CC2)c(Cl)c1.Cl,CCN(c1ccccc1)S(=O)(=O)c1ccc(NC(=O)CN(C)C2CCN(C)CC2)c(Cl)c1,Cl,= ,40.58,MRC-5 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10,1.0,F,MRC-5 cells,Human Lung Fibroblast Cells,ORGANISM,14.0,HEOS,,,,
CCN(c1ccccc1)S(=O)(=O)c1ccc(NC(=O)CN(C)C2CCN(C)CC2)c(Cl)c1.Cl,CCN(c1ccccc1)S(=O)(=O)c1ccc(NC(=O)CN(C)C2CCN(C)CC2)c(Cl)c1,Cl,= ,40.58,MRC-5 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10,1.0,F,MRC-5 cells,Human Lung Fibroblast Cells,ORGANISM,14.0,HEOS,,,,
CCN(c1ccccc1)S(=O)(=O)c1ccc(NC(=O)CN(C)C2CCN(C)CC2)c(Cl)c1.Cl,CCN(c1ccccc1)S(=O)(=O)c1ccc(NC(=O)CN(C)C2CCN(C)CC2)c(Cl)c1,Cl,= ,11.31,L. infantum,,,uM,,IC50,In Vitro,,Leish (macro) in Vitro,set10,1.0,F,L. infantum,MHOM/MA(BE)/67,ORGANISM,14.0,HEOS,,,,
CCN(c1ccccc1)S(=O)(=O)c1ccc(NC(=O)CN(C)C2CCN(C)CC2)c(Cl)c1.Cl,CCN(c1ccccc1)S(=O)(=O)c1ccc(NC(=O)CN(C)C2CCN(C)CC2)c(Cl)c1,Cl,= ,24.05,L. infantum,,,uM,,IC50,In Vitro,,Leish (macro) in Vitro,set10,1.0,F,L. infantum,MHOM/MA(BE)/67,ORGANISM,14.0,HEOS,,,,
CCN(c1ccccc1)S(=O)(=O)c1ccc(NC(=O)CN(C)C2CCN(C)CC2)c(Cl)c1.Cl,CCN(c1ccccc1)S(=O)(=O)c1ccc(NC(=O)CN(C)C2CCN(C)CC2)c(Cl)c1,Cl,= ,19.0,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
CCN(c1ccccc1)S(=O)(=O)c1ccc(NC(=O)CN(C)C2CCN(C)CC2)c(Cl)c1.Cl,CCN(c1ccccc1)S(=O)(=O)c1ccc(NC(=O)CN(C)C2CCN(C)CC2)c(Cl)c1,Cl,= ,2.9,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 3,ORGANISM,14.0,HEOS,,,,
CCN(c1ccccc1)S(=O)(=O)c1ccc(NC(=O)CN(C)C2CCN(C)CC2)c(Cl)c1.Cl,CCN(c1ccccc1)S(=O)(=O)c1ccc(NC(=O)CN(C)C2CCN(C)CC2)c(Cl)c1,Cl,= ,169.0,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CCN(c1ccccc1)S(=O)(=O)c1ccc(NC(=O)CN(C)C2CCN(C)CC2)c(Cl)c1.Cl,CCN(c1ccccc1)S(=O)(=O)c1ccc(NC(=O)CN(C)C2CCN(C)CC2)c(Cl)c1,Cl,= ,10.0,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CCN(c1ccccc1)S(=O)(=O)c1ccc(NC(=O)CN(C)C2CCN(C)CC2)c(Cl)c1.Cl,CCN(c1ccccc1)S(=O)(=O)c1ccc(NC(=O)CN(C)C2CCN(C)CC2)c(Cl)c1,Cl,= ,4.4,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
CCN(c1ccccc1)S(=O)(=O)c1ccc(NC(=O)CN(C)C2CCN(C)CC2)c(Cl)c1.Cl,CCN(c1ccccc1)S(=O)(=O)c1ccc(NC(=O)CN(C)C2CCN(C)CC2)c(Cl)c1,Cl,= ,0.87,Human,,,none,,EH,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CCN(c1ccccc1)S(=O)(=O)c1ccc(Cl)c(NC(=O)c2ccc3c(c2)CCNC3)c1,CCN(c1ccccc1)S(=O)(=O)c1ccc(Cl)c(NC(=O)c2ccc3c(c2)CCNC3)c1,.,= ,0.604,T.b. rhodesiense,,,uM,,IC50,In Vitro,,HAT in Vitro,set10,1.0,F,T.b. rhodesiense,ATCC 30027,ORGANISM,14.0,HEOS,,,,
CCN(c1ccccc1)S(=O)(=O)c1ccc(Cl)c(NC(=O)c2ccc3c(c2)CCNC3)c1,CCN(c1ccccc1)S(=O)(=O)c1ccc(Cl)c(NC(=O)c2ccc3c(c2)CCNC3)c1,.,= ,19.94,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
CCN(c1ccccc1)S(=O)(=O)c1ccc(Cl)c(NC(=O)c2ccc3c(c2)CCNC3)c1,CCN(c1ccccc1)S(=O)(=O)c1ccc(Cl)c(NC(=O)c2ccc3c(c2)CCNC3)c1,.,= ,29.37,MRC-5 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10,1.0,F,MRC-5 cells,Human Lung Fibroblast Cells,ORGANISM,14.0,HEOS,,,,
CCN(c1ccccc1)S(=O)(=O)c1ccc(Cl)c(NC(=O)c2ccc3c(c2)CCNC3)c1,CCN(c1ccccc1)S(=O)(=O)c1ccc(Cl)c(NC(=O)c2ccc3c(c2)CCNC3)c1,.,= ,29.37,MRC-5 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10,1.0,F,MRC-5 cells,Human Lung Fibroblast Cells,ORGANISM,14.0,HEOS,,,,
CCN(c1ccccc1)S(=O)(=O)c1ccc(Cl)c(NC(=O)c2ccc3c(c2)CCNC3)c1,CCN(c1ccccc1)S(=O)(=O)c1ccc(Cl)c(NC(=O)c2ccc3c(c2)CCNC3)c1,.,= ,2.16,L. infantum,,,uM,,IC50,In Vitro,,Leish (macro) in Vitro,set10,1.0,F,L. infantum,MHOM/MA(BE)/67,ORGANISM,14.0,HEOS,,,,
CCN(c1ccccc1)S(=O)(=O)c1ccc(Cl)c(NC(=O)c2ccc3c(c2)CCNC3)c1,CCN(c1ccccc1)S(=O)(=O)c1ccc(Cl)c(NC(=O)c2ccc3c(c2)CCNC3)c1,.,= ,8.0,L. infantum,,,uM,,IC50,In Vitro,,Leish (macro) in Vitro,set10,1.0,F,L. infantum,MHOM/MA(BE)/67,ORGANISM,14.0,HEOS,,,,
CCN(c1ccccc1)S(=O)(=O)c1ccc(Cl)c(NC(=O)c2ccc3c(c2)CCNC3)c1,CCN(c1ccccc1)S(=O)(=O)c1ccc(Cl)c(NC(=O)c2ccc3c(c2)CCNC3)c1,.,= ,5.83,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
CCN(c1ccccc1)S(=O)(=O)c1ccc(Cl)c(NC(=O)c2ccc3c(c2)CCNC3)c1,CCN(c1ccccc1)S(=O)(=O)c1ccc(Cl)c(NC(=O)c2ccc3c(c2)CCNC3)c1,.,= ,0.943,Human,,,none,,EH,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CCN(c1ccccc1)S(=O)(=O)c1ccc(Cl)c(NC(=O)c2ccc3c(c2)CCNC3)c1,CCN(c1ccccc1)S(=O)(=O)c1ccc(Cl)c(NC(=O)c2ccc3c(c2)CCNC3)c1,.,= ,95.87,0.01M HCl - pH 2,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10,1.0,A,0.01M HCl - pH 2,NEPH_RT,ORGANISM,14.0,HEOS,,,,
CCN(c1ccccc1)S(=O)(=O)c1ccc(Cl)c(NC(=O)c2ccc3c(c2)CCNC3)c1,CCN(c1ccccc1)S(=O)(=O)c1ccc(Cl)c(NC(=O)c2ccc3c(c2)CCNC3)c1,.,= ,14.47,PBS - pH 6.5,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10,1.0,A,PBS - pH 6.5,NEPH_RT,ORGANISM,14.0,HEOS,,,,
CCN(c1ccccc1)S(=O)(=O)c1ccc(Cl)c(NC(=O)c2ccc3c(c2)CCNC3)c1,CCN(c1ccccc1)S(=O)(=O)c1ccc(Cl)c(NC(=O)c2ccc3c(c2)CCNC3)c1,.,= ,5.2,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CCN(c1ccccc1)S(=O)(=O)c1ccc(Cl)c(NC(=O)c2ccc3c(c2)CCNC3)c1,CCN(c1ccccc1)S(=O)(=O)c1ccc(Cl)c(NC(=O)c2ccc3c(c2)CCNC3)c1,.,= ,333.8,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
*.CCOC(COc1ccc2cc(Br)ccc2c1)Cn1ccnc1,CCOC(COc1ccc2cc(Br)ccc2c1)Cn1ccnc1,*,= ,,T. cruzi,,,%,,% inhibition,In Vivo,,"Chagas in vivo at 20 mg/kg, 20 adm days",set10,1.0,F,T. cruzi,Tulahuen Swiss po,ORGANISM,14.0,HEOS,,,,
*.CCOC(COc1ccc2cc(Br)ccc2c1)Cn1ccnc1,CCOC(COc1ccc2cc(Br)ccc2c1)Cn1ccnc1,*,= ,0.059,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
*.CCOC(COc1ccc2cc(Br)ccc2c1)Cn1ccnc1,CCOC(COc1ccc2cc(Br)ccc2c1)Cn1ccnc1,*,= ,44.23,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
*.CCOC(COc1ccc2cc(Br)ccc2c1)Cn1ccnc1,CCOC(COc1ccc2cc(Br)ccc2c1)Cn1ccnc1,*,= ,0.016,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
*.CCOC(COc1ccc2cc(Br)ccc2c1)Cn1ccnc1,CCOC(COc1ccc2cc(Br)ccc2c1)Cn1ccnc1,*,= ,3.3,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 3,ORGANISM,14.0,HEOS,,,,
*.CCOC(COc1ccc2cc(Br)ccc2c1)Cn1ccnc1,CCOC(COc1ccc2cc(Br)ccc2c1)Cn1ccnc1,*,= ,14.0,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
*.CCOC(COc1ccc2cc(Br)ccc2c1)Cn1ccnc1,CCOC(COc1ccc2cc(Br)ccc2c1)Cn1ccnc1,*,= ,120.0,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
*.CCOC(COc1ccc2cc(Br)ccc2c1)Cn1ccnc1,CCOC(COc1ccc2cc(Br)ccc2c1)Cn1ccnc1,*,= ,12.5,PBS - pH 6.5,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10,1.0,A,PBS - pH 6.5,NEPH_RT,ORGANISM,14.0,HEOS,,,,
*.CCOC(COc1ccc2cc(Br)ccc2c1)Cn1ccnc1,CCOC(COc1ccc2cc(Br)ccc2c1)Cn1ccnc1,*,= ,4.5,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
*.CCOC(COc1ccc2cc(Br)ccc2c1)Cn1ccnc1,CCOC(COc1ccc2cc(Br)ccc2c1)Cn1ccnc1,*,= ,0.36,Human,,,none,,EH,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CCN(CC)S(=O)(=O)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,CCN(CC)S(=O)(=O)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,.,= ,0.0065,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CCN(CC)S(=O)(=O)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,CCN(CC)S(=O)(=O)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,.,= ,,Met ID,,,none,,Report,In Vitro,,Metabolism,set10,1.0,A,Met ID,unknown,ORGANISM,14.0,HEOS,,,,
CCN(CC)S(=O)(=O)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,CCN(CC)S(=O)(=O)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,.,= ,0.0235,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CCN(CC)S(=O)(=O)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,CCN(CC)S(=O)(=O)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,.,= ,,T. cruzi,,,%,,% inhibition,In Vivo,,"Chagas in vivo at 20 mg/kg, 20 adm days",set10,1.0,F,T. cruzi,Tulahuen Swiss po,ORGANISM,14.0,HEOS,,,,
CCN(CC)S(=O)(=O)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,CCN(CC)S(=O)(=O)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,.,= ,0.00803333333333333,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CCN(CC)S(=O)(=O)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,CCN(CC)S(=O)(=O)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,.,= ,0.0008,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CCN(CC)S(=O)(=O)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,CCN(CC)S(=O)(=O)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,.,= ,20.0,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
CCN(CC)S(=O)(=O)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,CCN(CC)S(=O)(=O)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,.,= ,2.7,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 3,ORGANISM,14.0,HEOS,,,,
CCN(CC)S(=O)(=O)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,CCN(CC)S(=O)(=O)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,.,= ,0.9,Human,,,none,,EH,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CCN(CC)S(=O)(=O)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,CCN(CC)S(=O)(=O)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,.,= ,3.2,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
CCN(CC)S(=O)(=O)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,CCN(CC)S(=O)(=O)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,.,= ,50.0,0.01M HCl - pH 2,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10,1.0,A,0.01M HCl - pH 2,NEPH_RT,ORGANISM,14.0,HEOS,,,,
CCN(CC)S(=O)(=O)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,CCN(CC)S(=O)(=O)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,.,= ,1.6,PBS - pH 6.5,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10,1.0,A,PBS - pH 6.5,NEPH_RT,ORGANISM,14.0,HEOS,,,,
CCN(CC)S(=O)(=O)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,CCN(CC)S(=O)(=O)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,.,= ,10.0,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CCN(CC)S(=O)(=O)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,CCN(CC)S(=O)(=O)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,.,= ,166.0,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,N#Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,.,= ,3.1,PBS - pH 6.5,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10,1.0,A,PBS - pH 6.5,NEPH_RT,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,N#Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,.,= ,113.0,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,N#Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,.,= ,15.0,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,N#Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,.,= ,1.9,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 3,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,N#Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,.,= ,,T. cruzi,,,%,,% inhibition,In Vivo,,"Chagas in vivo at 20 mg/kg, 20 adm days",set10,1.0,F,T. cruzi,Tulahuen Swiss po,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,N#Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,.,= ,0.084,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,N#Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,.,= ,53.53,L. donovani,,,%,,% inhibition,In Vitro,,Leish macro in vitro at 10 uM,set10,1.0,F,L. donovani,MHOM/ET/67/L82,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,N#Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,.,= ,50.0,0.01M HCl - pH 2,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10,1.0,A,0.01M HCl - pH 2,NEPH_RT,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,N#Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,.,= ,2.7,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,N#Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,.,= ,0.46,Human,,,none,,EH,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CCN(c1ccccc1)S(=O)(=O)c1ccc(Cl)c(NC(=O)CNC2CCCN(C)C2)c1.O=CO,CCN(c1ccccc1)S(=O)(=O)c1ccc(Cl)c(NC(=O)CNC2CCCN(C)C2)c1,O=CO,= ,0.91,T.b. rhodesiense,,,uM,,IC50,In Vitro,,HAT in Vitro,set10,1.0,F,T.b. rhodesiense,ATCC 30027,ORGANISM,14.0,HEOS,,,,
CCN(c1ccccc1)S(=O)(=O)c1ccc(Cl)c(NC(=O)CNC2CCCN(C)C2)c1.O=CO,CCN(c1ccccc1)S(=O)(=O)c1ccc(Cl)c(NC(=O)CNC2CCCN(C)C2)c1,O=CO,= ,45.66,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
CCN(c1ccccc1)S(=O)(=O)c1ccc(Cl)c(NC(=O)CNC2CCCN(C)C2)c1.O=CO,CCN(c1ccccc1)S(=O)(=O)c1ccc(Cl)c(NC(=O)CNC2CCCN(C)C2)c1,O=CO,= ,0.815,Human,,,none,,EH,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CCN(c1ccccc1)S(=O)(=O)c1ccc(Cl)c(NC(=O)CNC2CCCN(C)C2)c1.O=CO,CCN(c1ccccc1)S(=O)(=O)c1ccc(Cl)c(NC(=O)CNC2CCCN(C)C2)c1,O=CO,= ,1.56,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
CCN(c1ccccc1)S(=O)(=O)c1ccc(Cl)c(NC(=O)CNC2CCCN(C)C2)c1.O=CO,CCN(c1ccccc1)S(=O)(=O)c1ccc(Cl)c(NC(=O)CNC2CCCN(C)C2)c1,O=CO,= ,100.81,0.01M HCl - pH 2,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10,1.0,A,0.01M HCl - pH 2,NEPH_RT,ORGANISM,14.0,HEOS,,,,
CCN(c1ccccc1)S(=O)(=O)c1ccc(Cl)c(NC(=O)CNC2CCCN(C)C2)c1.O=CO,CCN(c1ccccc1)S(=O)(=O)c1ccc(Cl)c(NC(=O)CNC2CCCN(C)C2)c1,O=CO,= ,94.44,PBS - pH 6.5,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10,1.0,A,PBS - pH 6.5,NEPH_RT,ORGANISM,14.0,HEOS,,,,
CCN(c1ccccc1)S(=O)(=O)c1ccc(Cl)c(NC(=O)CNC2CCCN(C)C2)c1.O=CO,CCN(c1ccccc1)S(=O)(=O)c1ccc(Cl)c(NC(=O)CNC2CCCN(C)C2)c1,O=CO,= ,19.5,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CCN(c1ccccc1)S(=O)(=O)c1ccc(Cl)c(NC(=O)CNC2CCCN(C)C2)c1.O=CO,CCN(c1ccccc1)S(=O)(=O)c1ccc(Cl)c(NC(=O)CNC2CCCN(C)C2)c1,O=CO,= ,89.0,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CCN(c1ccccc1)S(=O)(=O)c1ccc(Cl)c(NC(=O)CNC2CCCN(C)C2)c1.O=CO,CCN(c1ccccc1)S(=O)(=O)c1ccc(Cl)c(NC(=O)CNC2CCCN(C)C2)c1,O=CO,= ,-0.12,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 3,ORGANISM,14.0,HEOS,,,,
CCN(c1ccccc1)S(=O)(=O)c1ccc(Cl)c(NC(=O)CNC2CCCN(C)C2)c1.O=CO,CCN(c1ccccc1)S(=O)(=O)c1ccc(Cl)c(NC(=O)CNC2CCCN(C)C2)c1,O=CO,= ,16.3,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,CS(=O)(=O)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,.,= ,2.3,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,CS(=O)(=O)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,.,= ,50.0,0.01M HCl - pH 2,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10,1.0,A,0.01M HCl - pH 2,NEPH_RT,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,CS(=O)(=O)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,.,= ,12.5,PBS - pH 6.5,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10,1.0,A,PBS - pH 6.5,NEPH_RT,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,CS(=O)(=O)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,.,= ,1.7,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 3,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,CS(=O)(=O)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,.,= ,0.09,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,CS(=O)(=O)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,.,= ,48.25,L. donovani,,,%,,% inhibition,In Vitro,,Leish macro in vitro at 10 uM,set10,1.0,F,L. donovani,MHOM/ET/67/L82,ORGANISM,14.0,HEOS,,,,
O=C(NCCc1cnc[nH]1)c1ccc2cc(Br)ccc2c1,O=C(NCCc1cnc[nH]1)c1ccc2cc(Br)ccc2c1,.,= ,3.28,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
O=C(NCCc1cnc[nH]1)c1ccc2cc(Br)ccc2c1,O=C(NCCc1cnc[nH]1)c1ccc2cc(Br)ccc2c1,.,= ,0.186,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
O=C(NCCc1cnc[nH]1)c1ccc2cc(Br)ccc2c1,O=C(NCCc1cnc[nH]1)c1ccc2cc(Br)ccc2c1,.,= ,59.74,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
O=C(NCCc1cnc[nH]1)c1ccc2cc(Br)ccc2c1,O=C(NCCc1cnc[nH]1)c1ccc2cc(Br)ccc2c1,.,= ,0.41,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 3,ORGANISM,14.0,HEOS,,,,
O=C(NCCc1cnc[nH]1)c1ccc2cc(Br)ccc2c1,O=C(NCCc1cnc[nH]1)c1ccc2cc(Br)ccc2c1,.,= ,16.5,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
O=C(NCCc1cnc[nH]1)c1ccc2cc(Br)ccc2c1,O=C(NCCc1cnc[nH]1)c1ccc2cc(Br)ccc2c1,.,= ,0.45,Human,,,none,,EH,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
O=C(NCCc1cnc[nH]1)c1ccc2cc(Br)ccc2c1,O=C(NCCc1cnc[nH]1)c1ccc2cc(Br)ccc2c1,.,= ,105.0,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
O=C(NCCc1cnc[nH]1)c1ccc2cc(Br)ccc2c1,O=C(NCCc1cnc[nH]1)c1ccc2cc(Br)ccc2c1,.,= ,48.24,PBS - pH 6.5,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10,1.0,A,PBS - pH 6.5,NEPH_RT,ORGANISM,14.0,HEOS,,,,
O=C(NCCc1cnc[nH]1)c1ccc2cc(Br)ccc2c1,O=C(NCCc1cnc[nH]1)c1ccc2cc(Br)ccc2c1,.,= ,64.26,0.01M HCl - pH 2,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10,1.0,A,0.01M HCl - pH 2,NEPH_RT,ORGANISM,14.0,HEOS,,,,
O=C(NCCc1cnc[nH]1)c1ccc2cc(Br)ccc2c1,O=C(NCCc1cnc[nH]1)c1ccc2cc(Br)ccc2c1,.,= ,3.03,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,.,= ,80.0,T. cruzi,,,%,,Parasitemia clearance after treatment,In Vivo,,"Chagas in vivo at 20 mg/kg, 20 days 2x",set10,1.0,F,T. cruzi,Tulahuen Swiss po,ORGANISM,14.0,HEOS,,,,
CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,.,= ,,T. cruzi,,,%,,% inhibition,In Vivo,,"Chagas in vivo at 20 mg/kg, 20 adm days",set10,1.0,F,T. cruzi,Tulahuen Swiss po,ORGANISM,14.0,HEOS,,,,
CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,.,= ,60.0,T. cruzi,,,%,,Parasitemia clearance after treatment,In Vivo,,"Chagas in vivo at 50 mg/kg, 20 days 1x",set10,1.0,F,T. cruzi,Tulahuen Swiss po,ORGANISM,14.0,HEOS,,,,
CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,.,= ,60.0,T. cruzi,,,%,,Parasitemia clearance after immunosuppression,In Vivo,,"Chagas in vivo at 20 mg/kg, 20 days 2x",set10,1.0,F,T. cruzi,Tulahuen Swiss po,ORGANISM,14.0,HEOS,,,,
CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,.,= ,0.0,T. cruzi,,,%,,Parasitemia clearance after immunosuppression,In Vivo,,"Chagas in vivo at 50 mg/kg, 20 days 1x",set10,1.0,F,T. cruzi,Tulahuen Swiss po,ORGANISM,14.0,HEOS,,,,
CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,.,= ,0.0,T. cruzi,,,%,,PCR cure rate,In Vivo,,"Chagas in vivo at 20 mg/kg, 20 days 2x",set10,1.0,F,T. cruzi,Tulahuen Swiss po,ORGANISM,14.0,HEOS,,,,
CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,.,= ,0.0,T. cruzi,,,%,,PCR cure rate,In Vivo,,"Chagas in vivo at 50 mg/kg, 20 days 1x",set10,1.0,F,T. cruzi,Tulahuen Swiss po,ORGANISM,14.0,HEOS,,,,
CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,.,= ,0.01049999999999999,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,.,= ,98.6,rat,,,%,,% bound,In Vitro,,protein binding,set10,1.0,A,rat,plasma,ORGANISM,14.0,HEOS,,,,
CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,.,= ,0.003,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,.,= ,97.2,mouse,,,%,,% bound,In Vitro,,protein binding,set10,1.0,A,mouse,plasma,ORGANISM,14.0,HEOS,,,,
CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,.,= ,0.4,Rat,,,none,,EH,In Vitro,,Metabolism,set10,1.0,A,Rat,Hepatocytes,ORGANISM,14.0,HEOS,,,,
CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,.,= ,0.008,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,.,= ,18.0,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,.,= ,38.0,Rat,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10,1.0,A,Rat,Microsomes,ORGANISM,14.0,HEOS,,,,
CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,.,= ,46.0,Rat,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10,1.0,A,Rat,Microsomes,ORGANISM,14.0,HEOS,,,,
CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,.,= ,2.6,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 3,ORGANISM,14.0,HEOS,,,,
CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,.,= ,52.0,Mouse,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10,1.0,A,Mouse,Microsomes,ORGANISM,14.0,HEOS,,,,
CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,.,= ,0.6,Mouse,,,none,,EH,In Vitro,,Metabolism,set10,1.0,A,Mouse,Microsomes,ORGANISM,14.0,HEOS,,,,
CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,.,= ,24.0,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,.,= ,34.0,Mouse,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10,1.0,A,Mouse,Microsomes,ORGANISM,14.0,HEOS,,,,
CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,.,= ,73.0,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,.,= ,3.4,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,.,= ,0.6,Rat,,,none,,EH,In Vitro,,Metabolism,set10,1.0,A,Rat,Microsomes,ORGANISM,14.0,HEOS,,,,
CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,.,= ,0.48,Human,,,none,,EH,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,.,= ,47.27,L. donovani,,,%,,% inhibition,In Vitro,,Leish macro in vitro at 10 uM,set10,1.0,F,L. donovani,MHOM/ET/67/L82,ORGANISM,14.0,HEOS,,,,
CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,.,= ,0.02584999999999999,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,.,= ,,T. cruzi,,,%,,% inhibition,In Vivo,,"Chagas in vivo at 20 mg/kg, 20 adm days",set10,1.0,F,T. cruzi,Tulahuen Swiss po,ORGANISM,14.0,HEOS,,,,
CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,.,= ,26.7,Rat,,,mL/min/kg,,CLblood,In Vitro,,Metabolism,set10,1.0,A,Rat,Hepatocytes,ORGANISM,14.0,HEOS,,,,
CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,.,= ,54.6,Rat,,,none,,% bound,In Vitro,,protein binding,set10,1.0,A,Rat,Liver Microsomes,ORGANISM,14.0,HEOS,,,,
O=C(NCCc1cnc[nH]1)c1cnc(-c2ccccc2)cn1,O=C(NCCc1cnc[nH]1)c1cnc(-c2ccccc2)cn1,.,= ,0.445,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
O=C(NCCc1cnc[nH]1)c1cnc(-c2ccccc2)cn1,O=C(NCCc1cnc[nH]1)c1cnc(-c2ccccc2)cn1,.,= ,0.52,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
O=C(NCCc1cnc[nH]1)c1cnc(-c2ccccc2)cn1,O=C(NCCc1cnc[nH]1)c1cnc(-c2ccccc2)cn1,.,= ,0.17,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
O=C(NCCc1cnc[nH]1)c1cnc(-c2ccccc2)cn1,O=C(NCCc1cnc[nH]1)c1cnc(-c2ccccc2)cn1,.,= ,0.093,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
O=C(NCCc1cnc[nH]1)c1cnc(-c2ccccc2)cn1,O=C(NCCc1cnc[nH]1)c1cnc(-c2ccccc2)cn1,.,= ,0.095,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
O=C(NCCc1cnc[nH]1)c1cnc(-c2ccccc2)cn1,O=C(NCCc1cnc[nH]1)c1cnc(-c2ccccc2)cn1,.,= ,0.627,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
O=C(NCCc1cnc[nH]1)c1cnc(-c2ccccc2)cn1,O=C(NCCc1cnc[nH]1)c1cnc(-c2ccccc2)cn1,.,= ,0.802,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
O=C(NCCc1cnc[nH]1)c1cnc(-c2ccccc2)cn1,O=C(NCCc1cnc[nH]1)c1cnc(-c2ccccc2)cn1,.,= ,0.149,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
O=C(NCCc1cnc[nH]1)c1cnc(-c2ccccc2)cn1,O=C(NCCc1cnc[nH]1)c1cnc(-c2ccccc2)cn1,.,= ,,PBS - pH 6.5,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10,1.0,A,PBS - pH 6.5,NEPH_RT,ORGANISM,14.0,HEOS,,,,
O=C(NCCc1cnc[nH]1)c1cnc(-c2ccccc2)cn1,O=C(NCCc1cnc[nH]1)c1cnc(-c2ccccc2)cn1,.,= ,1.3,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 3,ORGANISM,14.0,HEOS,,,,
O=C(NCCc1cnc[nH]1)c1cnc(-c2ccccc2)cn1,O=C(NCCc1cnc[nH]1)c1cnc(-c2ccccc2)cn1,.,= ,16.0,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
O=C(NCCc1cnc[nH]1)c1cnc(-c2ccccc2)cn1,O=C(NCCc1cnc[nH]1)c1cnc(-c2ccccc2)cn1,.,= ,0.057,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
O=C(NCCc1cnc[nH]1)c1cnc(-c2ccccc2)cn1,O=C(NCCc1cnc[nH]1)c1cnc(-c2ccccc2)cn1,.,= ,19.73,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
O=C(NCCc1cnc[nH]1)c1cnc(-c2ccccc2)cn1,O=C(NCCc1cnc[nH]1)c1cnc(-c2ccccc2)cn1,.,= ,0.29075,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
O=C(NCCc1cnc[nH]1)c1cnc(-c2ccccc2)cn1,O=C(NCCc1cnc[nH]1)c1cnc(-c2ccccc2)cn1,.,= ,2.1,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
CN(CC(O)COc1ccc2cc(Br)ccc2c1)C1CCCCC1,CN(CC(O)COc1ccc2cc(Br)ccc2c1)C1CCCCC1,.,= ,0.525,T.b. rhodesiense,,,uM,,IC50,In Vitro,,HAT in Vitro,set10,1.0,F,T.b. rhodesiense,ATCC 30027,ORGANISM,14.0,HEOS,,,,
CN(CC(O)COc1ccc2cc(Br)ccc2c1)C1CCCCC1,CN(CC(O)COc1ccc2cc(Br)ccc2c1)C1CCCCC1,.,= ,8.48,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CN(CC(O)COc1ccc2cc(Br)ccc2c1)C1CCCCC1,CN(CC(O)COc1ccc2cc(Br)ccc2c1)C1CCCCC1,.,= ,16.56,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
CN(CC(O)COc1ccc2cc(Br)ccc2c1)C1CCCCC1,CN(CC(O)COc1ccc2cc(Br)ccc2c1)C1CCCCC1,.,= ,1.26,L. infantum,,,uM,,IC50,In Vitro,,Leish (macro) in Vitro,set10,1.0,F,L. infantum,MHOM/MA(BE)/67,ORGANISM,14.0,HEOS,,,,
CN(CC(O)COc1ccc2cc(Br)ccc2c1)C1CCCCC1,CN(CC(O)COc1ccc2cc(Br)ccc2c1)C1CCCCC1,.,= ,1.68,L. infantum,,,uM,,IC50,In Vitro,,Leish (macro) in Vitro,set10,1.0,F,L. infantum,MHOM/MA(BE)/67,ORGANISM,14.0,HEOS,,,,
CN(CC(O)COc1ccc2cc(Br)ccc2c1)C1CCCCC1,CN(CC(O)COc1ccc2cc(Br)ccc2c1)C1CCCCC1,.,= ,2.0,L. infantum,,,uM,,IC50,In Vitro,,Leish (macro) in Vitro,set10,1.0,F,L. infantum,MHOM/MA(BE)/67,ORGANISM,14.0,HEOS,,,,
CN(CC(O)COc1ccc2cc(Br)ccc2c1)C1CCCCC1,CN(CC(O)COc1ccc2cc(Br)ccc2c1)C1CCCCC1,.,= ,4.55,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CN(CC(O)COc1ccc2cc(Br)ccc2c1)C1CCCCC1,CN(CC(O)COc1ccc2cc(Br)ccc2c1)C1CCCCC1,.,= ,17.0,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
CN(CC(O)COc1ccc2cc(Br)ccc2c1)C1CCCCC1,CN(CC(O)COc1ccc2cc(Br)ccc2c1)C1CCCCC1,.,= ,7.84,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CN(CC(O)COc1ccc2cc(Br)ccc2c1)C1CCCCC1,CN(CC(O)COc1ccc2cc(Br)ccc2c1)C1CCCCC1,.,= ,1.76,T.b. rhodesiense,,,uM,,IC50,In Vitro,,HAT in Vitro,set10,1.0,F,T.b. rhodesiense,ATCC 30027,ORGANISM,14.0,HEOS,,,,
CN(CC(O)COc1ccc2cc(Br)ccc2c1)C1CCCCC1,CN(CC(O)COc1ccc2cc(Br)ccc2c1)C1CCCCC1,.,= ,11.0,CYP3A4,,,%,,% inhibition,In Vitro,,CYP Inhibition at 10 uM,set10,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
CN(CC(O)COc1ccc2cc(Br)ccc2c1)C1CCCCC1,CN(CC(O)COc1ccc2cc(Br)ccc2c1)C1CCCCC1,.,= ,1.68,T.b. rhodesiense,,,uM,,IC50,In Vitro,,HAT in Vitro,set10,1.0,F,T.b. rhodesiense,ATCC 30027,ORGANISM,14.0,HEOS,,,,
CN(CC(O)COc1ccc2cc(Br)ccc2c1)C1CCCCC1,CN(CC(O)COc1ccc2cc(Br)ccc2c1)C1CCCCC1,.,= ,0.7115,T.b. rhodesiense,,,uM,,IC50,In Vitro,,HAT in Vitro,set10,1.0,F,T.b. rhodesiense,ATCC 30027,ORGANISM,14.0,HEOS,,,,
CN(CC(O)COc1ccc2cc(Br)ccc2c1)C1CCCCC1,CN(CC(O)COc1ccc2cc(Br)ccc2c1)C1CCCCC1,.,= ,1.15,T.b. rhodesiense,,,uM,,IC50,In Vitro,,HAT in Vitro,set10,1.0,F,T.b. rhodesiense,ATCC 30027,ORGANISM,14.0,HEOS,,,,
CN(CC(O)COc1ccc2cc(Br)ccc2c1)C1CCCCC1,CN(CC(O)COc1ccc2cc(Br)ccc2c1)C1CCCCC1,.,= ,1.66,T.b. rhodesiense,,,uM,,IC50,In Vitro,,HAT in Vitro,set10,1.0,F,T.b. rhodesiense,ATCC 30027,ORGANISM,14.0,HEOS,,,,
CN(CC(O)COc1ccc2cc(Br)ccc2c1)C1CCCCC1,CN(CC(O)COc1ccc2cc(Br)ccc2c1)C1CCCCC1,.,= ,0.34,Human,,,none,,EH,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CN(CC(O)COc1ccc2cc(Br)ccc2c1)C1CCCCC1,CN(CC(O)COc1ccc2cc(Br)ccc2c1)C1CCCCC1,.,= ,3.6,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
CN(CC(O)COc1ccc2cc(Br)ccc2c1)C1CCCCC1,CN(CC(O)COc1ccc2cc(Br)ccc2c1)C1CCCCC1,.,= ,132.0,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CN(CC(O)COc1ccc2cc(Br)ccc2c1)C1CCCCC1,CN(CC(O)COc1ccc2cc(Br)ccc2c1)C1CCCCC1,.,= ,13.0,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CN(CC(O)COc1ccc2cc(Br)ccc2c1)C1CCCCC1,CN(CC(O)COc1ccc2cc(Br)ccc2c1)C1CCCCC1,.,= ,2.6,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 3,ORGANISM,14.0,HEOS,,,,
CN(CC(O)COc1ccc2cc(Br)ccc2c1)C1CCCCC1,CN(CC(O)COc1ccc2cc(Br)ccc2c1)C1CCCCC1,.,= ,4.64,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CN(CC(O)COc1ccc2cc(Br)ccc2c1)C1CCCCC1,CN(CC(O)COc1ccc2cc(Br)ccc2c1)C1CCCCC1,.,= ,5.0,CYP3A4,,,%,,% inhibition,In Vitro,,CYP Inhibition at 1 uM,set10,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
CC(C)N(C)CC(O)COc1ccc2cc(Br)ccc2c1,CC(C)N(C)CC(O)COc1ccc2cc(Br)ccc2c1,.,= ,0.507,T.b. rhodesiense,,,uM,,IC50,In Vitro,,HAT in Vitro,set10,1.0,F,T.b. rhodesiense,ATCC 30027,ORGANISM,14.0,HEOS,,,,
CC(C)N(C)CC(O)COc1ccc2cc(Br)ccc2c1,CC(C)N(C)CC(O)COc1ccc2cc(Br)ccc2c1,.,= ,8.78,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CC(C)N(C)CC(O)COc1ccc2cc(Br)ccc2c1,CC(C)N(C)CC(O)COc1ccc2cc(Br)ccc2c1,.,= ,8.95,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CC(C)N(C)CC(O)COc1ccc2cc(Br)ccc2c1,CC(C)N(C)CC(O)COc1ccc2cc(Br)ccc2c1,.,= ,8.79,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CC(C)N(C)CC(O)COc1ccc2cc(Br)ccc2c1,CC(C)N(C)CC(O)COc1ccc2cc(Br)ccc2c1,.,= ,19.2,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
CC(C)N(C)CC(O)COc1ccc2cc(Br)ccc2c1,CC(C)N(C)CC(O)COc1ccc2cc(Br)ccc2c1,.,= ,3.6,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
CC(C)N(C)CC(O)COc1ccc2cc(Br)ccc2c1,CC(C)N(C)CC(O)COc1ccc2cc(Br)ccc2c1,.,= ,2.6,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 3,ORGANISM,14.0,HEOS,,,,
CC(C)N(C)CC(O)COc1ccc2cc(Br)ccc2c1,CC(C)N(C)CC(O)COc1ccc2cc(Br)ccc2c1,.,= ,6.4,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CC(C)N(C)CC(O)COc1ccc2cc(Br)ccc2c1,CC(C)N(C)CC(O)COc1ccc2cc(Br)ccc2c1,.,= ,5.43,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CC(C)N(C)CC(O)COc1ccc2cc(Br)ccc2c1,CC(C)N(C)CC(O)COc1ccc2cc(Br)ccc2c1,.,= ,5.75,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CC(C)N(C)CC(O)COc1ccc2cc(Br)ccc2c1,CC(C)N(C)CC(O)COc1ccc2cc(Br)ccc2c1,.,= ,5.78,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CC(C)N(C)CC(O)COc1ccc2cc(Br)ccc2c1,CC(C)N(C)CC(O)COc1ccc2cc(Br)ccc2c1,.,= ,6.73,L. infantum,,,uM,,IC50,In Vitro,,Leish (macro) in Vitro,set10,1.0,F,L. infantum,MHOM/MA(BE)/67,ORGANISM,14.0,HEOS,,,,
CC(C)N(C)CC(O)COc1ccc2cc(Br)ccc2c1,CC(C)N(C)CC(O)COc1ccc2cc(Br)ccc2c1,.,= ,6.57,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CC(C)N(C)CC(O)COc1ccc2cc(Br)ccc2c1,CC(C)N(C)CC(O)COc1ccc2cc(Br)ccc2c1,.,= ,34.83,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
CC(C)N(C)CC(O)COc1ccc2cc(Br)ccc2c1,CC(C)N(C)CC(O)COc1ccc2cc(Br)ccc2c1,.,= ,1.55,T.b. rhodesiense,,,uM,,IC50,In Vitro,,HAT in Vitro,set10,1.0,F,T.b. rhodesiense,ATCC 30027,ORGANISM,14.0,HEOS,,,,
CC(C)N(C)CC(O)COc1ccc2cc(Br)ccc2c1,CC(C)N(C)CC(O)COc1ccc2cc(Br)ccc2c1,.,= ,2.38,L. infantum,,,uM,,IC50,In Vitro,,Leish (macro) in Vitro,set10,1.0,F,L. infantum,MHOM/MA(BE)/67,ORGANISM,14.0,HEOS,,,,
CC(C)N(C)CC(O)COc1ccc2cc(Br)ccc2c1,CC(C)N(C)CC(O)COc1ccc2cc(Br)ccc2c1,.,= ,6.73,L. infantum,,,uM,,IC50,In Vitro,,Leish (macro) in Vitro,set10,1.0,F,L. infantum,MHOM/MA(BE)/67,ORGANISM,14.0,HEOS,,,,
CCN(Cc1cccnc1)c1cccc(-c2nc3ccccc3s2)c1,CCN(Cc1cccnc1)c1cccc(-c2nc3ccccc3s2)c1,.,= ,0.005,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CCN(Cc1cccnc1)c1cccc(-c2nc3ccccc3s2)c1,CCN(Cc1cccnc1)c1cccc(-c2nc3ccccc3s2)c1,.,= ,0.003,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CCN(Cc1cccnc1)c1cccc(-c2nc3ccccc3s2)c1,CCN(Cc1cccnc1)c1cccc(-c2nc3ccccc3s2)c1,.,= ,41.91,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
CCN(Cc1cccnc1)c1cccc(-c2nc3ccccc3s2)c1,CCN(Cc1cccnc1)c1cccc(-c2nc3ccccc3s2)c1,.,= ,0.145,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CCN(Cc1cccnc1)c1cccc(-c2nc3ccccc3s2)c1,CCN(Cc1cccnc1)c1cccc(-c2nc3ccccc3s2)c1,.,= ,0.174,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CCN(Cc1cccnc1)c1cccc(-c2nc3ccccc3s2)c1,CCN(Cc1cccnc1)c1cccc(-c2nc3ccccc3s2)c1,.,= ,0.442,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CCN(Cc1cccnc1)c1cccc(-c2nc3ccccc3s2)c1,CCN(Cc1cccnc1)c1cccc(-c2nc3ccccc3s2)c1,.,= ,1.0,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
CCN(Cc1cccnc1)c1cccc(-c2nc3ccccc3s2)c1,CCN(Cc1cccnc1)c1cccc(-c2nc3ccccc3s2)c1,.,= ,4.1,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 3,ORGANISM,14.0,HEOS,,,,
CCN(Cc1cccnc1)c1cccc(-c2nc3ccccc3s2)c1,CCN(Cc1cccnc1)c1cccc(-c2nc3ccccc3s2)c1,.,= ,159.0,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CCN(Cc1cccnc1)c1cccc(-c2nc3ccccc3s2)c1,CCN(Cc1cccnc1)c1cccc(-c2nc3ccccc3s2)c1,.,= ,11.0,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CCN(Cc1cccnc1)c1cccc(-c2nc3ccccc3s2)c1,CCN(Cc1cccnc1)c1cccc(-c2nc3ccccc3s2)c1,.,= ,4.9,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
CCN(Cc1cccnc1)c1cccc(-c2nc3ccccc3s2)c1,CCN(Cc1cccnc1)c1cccc(-c2nc3ccccc3s2)c1,.,= ,0.86,Human,,,none,,EH,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CCN(Cc1cccnc1)c1cccc(-c2nc3ccccc3s2)c1,CCN(Cc1cccnc1)c1cccc(-c2nc3ccccc3s2)c1,.,= ,0.293,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CN1CCC(NCC(O)COc2ccc3cc(Br)ccc3c2)CC1,CN1CCC(NCC(O)COc2ccc3cc(Br)ccc3c2)CC1,.,= ,0.028,T.b. rhodesiense,,,uM,,IC50,In Vitro,,HAT in Vitro,set10,1.0,F,T.b. rhodesiense,ATCC 30027,ORGANISM,14.0,HEOS,,,,
CN1CCC(NCC(O)COc2ccc3cc(Br)ccc3c2)CC1,CN1CCC(NCC(O)COc2ccc3cc(Br)ccc3c2)CC1,.,= ,5.67,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CN1CCC(NCC(O)COc2ccc3cc(Br)ccc3c2)CC1,CN1CCC(NCC(O)COc2ccc3cc(Br)ccc3c2)CC1,.,= ,5.65,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
CN1CCC(NCC(O)COc2ccc3cc(Br)ccc3c2)CC1,CN1CCC(NCC(O)COc2ccc3cc(Br)ccc3c2)CC1,.,= ,0.053,T. b. brucei,,,uM,,IC50,In Vitro,,HAT in Vitro,set10,1.0,F,T. b. brucei,SBRI 427,ORGANISM,14.0,HEOS,,,,
CN1CCC(NCC(O)COc2ccc3cc(Br)ccc3c2)CC1,CN1CCC(NCC(O)COc2ccc3cc(Br)ccc3c2)CC1,.,= ,0.0745,T.b. rhodesiense,,,uM,,IC50,In Vitro,,HAT in Vitro,set10,1.0,F,T.b. rhodesiense,ATCC 30027,ORGANISM,14.0,HEOS,,,,
CN1CCC(NCC(O)COc2ccc3cc(Br)ccc3c2)CC1,CN1CCC(NCC(O)COc2ccc3cc(Br)ccc3c2)CC1,.,= ,4.98,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
CN1CCC(NCC(O)COc2ccc3cc(Br)ccc3c2)CC1,CN1CCC(NCC(O)COc2ccc3cc(Br)ccc3c2)CC1,.,= ,7.0,T. b. brucei,,,day,,MSD,In Vivo,,"HAT in vivo at 50 mg/kg, 4 adm days",set10,1.0,F,T. b. brucei,EATRO 110 po,ORGANISM,14.0,HEOS,,,,
CN1CCC(NCC(O)COc2ccc3cc(Br)ccc3c2)CC1,CN1CCC(NCC(O)COc2ccc3cc(Br)ccc3c2)CC1,.,= ,0.8534999999999999,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CN1CCC(NCC(O)COc2ccc3cc(Br)ccc3c2)CC1,CN1CCC(NCC(O)COc2ccc3cc(Br)ccc3c2)CC1,.,= ,95.2,mouse,,,%,,% bound,In Vitro,,protein binding,set10,1.0,A,mouse,plasma,ORGANISM,14.0,HEOS,,,,
CN1CCC(NCC(O)COc2ccc3cc(Br)ccc3c2)CC1,CN1CCC(NCC(O)COc2ccc3cc(Br)ccc3c2)CC1,.,= ,17.0,CYP2D6,,,uM,,IC50,In Vitro,,CYP Inhibition,set10,1.0,A,CYP2D6,unknown,ORGANISM,14.0,HEOS,,,,
CN1CCC(NCC(O)COc2ccc3cc(Br)ccc3c2)CC1,CN1CCC(NCC(O)COc2ccc3cc(Br)ccc3c2)CC1,.,= ,44.4,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
CN1CCC(NCC(O)COc2ccc3cc(Br)ccc3c2)CC1,CN1CCC(NCC(O)COc2ccc3cc(Br)ccc3c2)CC1,.,= ,3.66,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CN1CCC(NCC(O)COc2ccc3cc(Br)ccc3c2)CC1,CN1CCC(NCC(O)COc2ccc3cc(Br)ccc3c2)CC1,.,= ,0.4260901808738709,L. infantum,,,uM,,IC50,In Vitro,,Leish (macro) in Vitro,set10,1.0,F,L. infantum,MHOM/MA(BE)/67,ORGANISM,14.0,HEOS,,,,
CN1CCC(NCC(O)COc2ccc3cc(Br)ccc3c2)CC1,CN1CCC(NCC(O)COc2ccc3cc(Br)ccc3c2)CC1,.,= ,0.19842512905597687,L. infantum,,,uM,,IC50,In Vitro,,Leish (macro) in Vitro,set10,1.0,F,L. infantum,MHOM/MA(BE)/67,ORGANISM,14.0,HEOS,,,,
CN1CCC(NCC(O)COc2ccc3cc(Br)ccc3c2)CC1,CN1CCC(NCC(O)COc2ccc3cc(Br)ccc3c2)CC1,.,= ,0.5,L. infantum,,,uM,,IC50,In Vitro,,Leish (macro) in Vitro,set10,1.0,F,L. infantum,MHOM/MA(BE)/67,ORGANISM,14.0,HEOS,,,,
CN1CCC(NCC(O)COc2ccc3cc(Br)ccc3c2)CC1,CN1CCC(NCC(O)COc2ccc3cc(Br)ccc3c2)CC1,.,= ,2.11,MRC-5 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10,1.0,F,MRC-5 cells,Human Lung Fibroblast Cells,ORGANISM,14.0,HEOS,,,,
CN1CCC(NCC(O)COc2ccc3cc(Br)ccc3c2)CC1,CN1CCC(NCC(O)COc2ccc3cc(Br)ccc3c2)CC1,.,= ,6.65,MRC-5 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10,1.0,F,MRC-5 cells,Human Lung Fibroblast Cells,ORGANISM,14.0,HEOS,,,,
CN1CCC(NCC(O)COc2ccc3cc(Br)ccc3c2)CC1,CN1CCC(NCC(O)COc2ccc3cc(Br)ccc3c2)CC1,.,= ,2.04,MRC-5 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10,1.0,F,MRC-5 cells,Human Lung Fibroblast Cells,ORGANISM,14.0,HEOS,,,,
CN1CCC(NCC(O)COc2ccc3cc(Br)ccc3c2)CC1,CN1CCC(NCC(O)COc2ccc3cc(Br)ccc3c2)CC1,.,= ,5.69,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
CN1CCC(NCC(O)COc2ccc3cc(Br)ccc3c2)CC1,CN1CCC(NCC(O)COc2ccc3cc(Br)ccc3c2)CC1,.,= ,8.2,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CN1CCC(NCC(O)COc2ccc3cc(Br)ccc3c2)CC1,CN1CCC(NCC(O)COc2ccc3cc(Br)ccc3c2)CC1,.,= ,0.057,T.b. rhodesiense,,,uM,,IC50,In Vitro,,HAT in Vitro,set10,1.0,F,T.b. rhodesiense,ATCC 30027,ORGANISM,14.0,HEOS,,,,
CN1CCC(NCC(O)COc2ccc3cc(Br)ccc3c2)CC1,CN1CCC(NCC(O)COc2ccc3cc(Br)ccc3c2)CC1,.,= ,44.9,L. infantum,,,%,,% inhibition in spleen,In Vivo,,"Leish In Vivo - % inhibition and MSD at 50 mg/kg, 5 days 2x",set10,1.0,F,L. infantum,MHOM/MA(BE)/67 Hamster-Early curative model po,ORGANISM,14.0,HEOS,,,,
CN1CCC(NCC(O)COc2ccc3cc(Br)ccc3c2)CC1,CN1CCC(NCC(O)COc2ccc3cc(Br)ccc3c2)CC1,.,= ,26.8,L. infantum,,,%,,% inhibition in liver,In Vivo,,"Leish In Vivo - % inhibition and MSD at 50 mg/kg, 5 days 2x",set10,1.0,F,L. infantum,MHOM/MA(BE)/67 Hamster-Early curative model po,ORGANISM,14.0,HEOS,,,,
CN1CCC(NCC(O)COc2ccc3cc(Br)ccc3c2)CC1,CN1CCC(NCC(O)COc2ccc3cc(Br)ccc3c2)CC1,.,= ,41.4,L. infantum,,,%,,% inhibition in bone-marrow,In Vivo,,"Leish In Vivo - % inhibition and MSD at 50 mg/kg, 5 days 2x",set10,1.0,F,L. infantum,MHOM/MA(BE)/67 Hamster-Early curative model po,ORGANISM,14.0,HEOS,,,,
CN1CCC(NCC(O)COc2ccc3cc(Br)ccc3c2)CC1,CN1CCC(NCC(O)COc2ccc3cc(Br)ccc3c2)CC1,.,= ,1.93,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CN1CCC(NCC(O)COc2ccc3cc(Br)ccc3c2)CC1,CN1CCC(NCC(O)COc2ccc3cc(Br)ccc3c2)CC1,.,= ,0.22,Rat,,,none,,EH,In Vitro,,Metabolism,set10,1.0,A,Rat,Microsomes,ORGANISM,14.0,HEOS,,,,
CN1CCC(NCC(O)COc2ccc3cc(Br)ccc3c2)CC1,CN1CCC(NCC(O)COc2ccc3cc(Br)ccc3c2)CC1,.,= ,0.98,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
CN1CCC(NCC(O)COc2ccc3cc(Br)ccc3c2)CC1,CN1CCC(NCC(O)COc2ccc3cc(Br)ccc3c2)CC1,.,= ,9.0,Rat,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10,1.0,A,Rat,Microsomes,ORGANISM,14.0,HEOS,,,,
CN1CCC(NCC(O)COc2ccc3cc(Br)ccc3c2)CC1,CN1CCC(NCC(O)COc2ccc3cc(Br)ccc3c2)CC1,.,= ,203.0,Rat,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10,1.0,A,Rat,Microsomes,ORGANISM,14.0,HEOS,,,,
CN1CCCC(CNCC(O)COc2ccc3cc(Br)ccc3c2)C1,CN1CCCC(CNCC(O)COc2ccc3cc(Br)ccc3c2)C1,.,= ,5.56,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CN1CCCC(CNCC(O)COc2ccc3cc(Br)ccc3c2)C1,CN1CCCC(CNCC(O)COc2ccc3cc(Br)ccc3c2)C1,.,= ,7.12,T.b. rhodesiense,,,uM,,IC50,In Vitro,,HAT in Vitro,set10,1.0,F,T.b. rhodesiense,ATCC 30027,ORGANISM,14.0,HEOS,,,,
CN1CCCC(CNCC(O)COc2ccc3cc(Br)ccc3c2)C1,CN1CCCC(CNCC(O)COc2ccc3cc(Br)ccc3c2)C1,.,= ,19.02,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
CN1CCCC(CNCC(O)COc2ccc3cc(Br)ccc3c2)C1,CN1CCCC(CNCC(O)COc2ccc3cc(Br)ccc3c2)C1,.,= ,5.42,MRC-5 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10,1.0,F,MRC-5 cells,Human Lung Fibroblast Cells,ORGANISM,14.0,HEOS,,,,
CN1CCCC(CNCC(O)COc2ccc3cc(Br)ccc3c2)C1,CN1CCCC(CNCC(O)COc2ccc3cc(Br)ccc3c2)C1,.,= ,6.94,MRC-5 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10,1.0,F,MRC-5 cells,Human Lung Fibroblast Cells,ORGANISM,14.0,HEOS,,,,
CN1CCCC(CNCC(O)COc2ccc3cc(Br)ccc3c2)C1,CN1CCCC(CNCC(O)COc2ccc3cc(Br)ccc3c2)C1,.,= ,2.05,MRC-5 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10,1.0,F,MRC-5 cells,Human Lung Fibroblast Cells,ORGANISM,14.0,HEOS,,,,
CN1CCCC(CNCC(O)COc2ccc3cc(Br)ccc3c2)C1,CN1CCCC(CNCC(O)COc2ccc3cc(Br)ccc3c2)C1,.,= ,2.03,L. infantum,,,uM,,IC50,In Vitro,,Leish (macro) in Vitro,set10,1.0,F,L. infantum,MHOM/MA(BE)/67,ORGANISM,14.0,HEOS,,,,
CN1CCCC(CNCC(O)COc2ccc3cc(Br)ccc3c2)C1,CN1CCCC(CNCC(O)COc2ccc3cc(Br)ccc3c2)C1,.,= ,1.7,L. infantum,,,uM,,IC50,In Vitro,,Leish (macro) in Vitro,set10,1.0,F,L. infantum,MHOM/MA(BE)/67,ORGANISM,14.0,HEOS,,,,
CN1CCCC(CNCC(O)COc2ccc3cc(Br)ccc3c2)C1,CN1CCCC(CNCC(O)COc2ccc3cc(Br)ccc3c2)C1,.,= ,0.5400298833847046,L. infantum,,,uM,,IC50,In Vitro,,Leish (macro) in Vitro,set10,1.0,F,L. infantum,MHOM/MA(BE)/67,ORGANISM,14.0,HEOS,,,,
O=C(C1CC1)N(Cc1cccnc1)c1cccc(-c2nc3ccccc3s2)c1,O=C(C1CC1)N(Cc1cccnc1)c1cccc(-c2nc3ccccc3s2)c1,.,= ,0.94,Human,,,none,,EH,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
O=C(C1CC1)N(Cc1cccnc1)c1cccc(-c2nc3ccccc3s2)c1,O=C(C1CC1)N(Cc1cccnc1)c1cccc(-c2nc3ccccc3s2)c1,.,= ,4.0,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
O=C(C1CC1)N(Cc1cccnc1)c1cccc(-c2nc3ccccc3s2)c1,O=C(C1CC1)N(Cc1cccnc1)c1cccc(-c2nc3ccccc3s2)c1,.,= ,,PBS - pH 6.5,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10,1.0,A,PBS - pH 6.5,NEPH_RT,ORGANISM,14.0,HEOS,,,,
O=C(C1CC1)N(Cc1cccnc1)c1cccc(-c2nc3ccccc3s2)c1,O=C(C1CC1)N(Cc1cccnc1)c1cccc(-c2nc3ccccc3s2)c1,.,= ,5.0,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
O=C(C1CC1)N(Cc1cccnc1)c1cccc(-c2nc3ccccc3s2)c1,O=C(C1CC1)N(Cc1cccnc1)c1cccc(-c2nc3ccccc3s2)c1,.,= ,380.0,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
O=C(C1CC1)N(Cc1cccnc1)c1cccc(-c2nc3ccccc3s2)c1,O=C(C1CC1)N(Cc1cccnc1)c1cccc(-c2nc3ccccc3s2)c1,.,= ,3.4,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 3,ORGANISM,14.0,HEOS,,,,
O=C(C1CC1)N(Cc1cccnc1)c1cccc(-c2nc3ccccc3s2)c1,O=C(C1CC1)N(Cc1cccnc1)c1cccc(-c2nc3ccccc3s2)c1,.,= ,1.4,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
O=C(C1CC1)N(Cc1cccnc1)c1cccc(-c2nc3ccccc3s2)c1,O=C(C1CC1)N(Cc1cccnc1)c1cccc(-c2nc3ccccc3s2)c1,.,= ,0.029,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
O=C(C1CC1)N(Cc1cccnc1)c1cccc(-c2nc3ccccc3s2)c1,O=C(C1CC1)N(Cc1cccnc1)c1cccc(-c2nc3ccccc3s2)c1,.,= ,60.57,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,N#Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,,T. cruzi,,,%,,% inhibition,In Vivo,,"Chagas in vivo at 20 mg/kg, 20 adm days",set10,1.0,F,T. cruzi,Tulahuen Swiss po,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,N#Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,0.02049999999999999,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,N#Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,0.006,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,N#Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,4.5,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,N#Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,56.0,Mouse,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10,1.0,A,Mouse,Microsomes,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,N#Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,0.58,Mouse,,,none,,EH,In Vitro,,Metabolism,set10,1.0,A,Mouse,Microsomes,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,N#Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,11.0,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,N#Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,31.0,Mouse,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10,1.0,A,Mouse,Microsomes,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,N#Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,152.0,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,N#Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,,PBS - pH 6.5,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10,1.0,A,PBS - pH 6.5,NEPH_RT,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,N#Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,2.8,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,N#Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,0.31,Human,,,none,,EH,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,N#Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,47.7,Rat,,,none,,% bound,In Vitro,,protein binding,set10,1.0,A,Rat,Liver Microsomes,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,N#Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,17.2,Rat,,,mL/min/kg,,CLblood,In Vitro,,Metabolism,set10,1.0,A,Rat,Hepatocytes,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,N#Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,,T. cruzi,,,%,,% inhibition,In Vivo,,"Chagas in vivo at 20 mg/kg, 20 adm days",set10,1.0,F,T. cruzi,Tulahuen Swiss po,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,N#Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,25.0,Rat,,,mL/min/kg,,CLblood,In Vitro,,Metabolism,set10,1.0,A,Rat,Microsomes,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,N#Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,0.047,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,N#Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,95.7,rat,,,%,,% bound,In Vitro,,protein binding,set10,1.0,A,rat,plasma,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,N#Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,0.25,Rat,,,none,,EH,In Vitro,,Metabolism,set10,1.0,A,Rat,Hepatocytes,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,N#Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,0.0115,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,N#Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,93.6,mouse,,,%,,% bound,In Vitro,,protein binding,set10,1.0,A,mouse,plasma,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,N#Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,73.0,Rat,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10,1.0,A,Rat,Microsomes,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,N#Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,24.0,Rat,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10,1.0,A,Rat,Microsomes,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,N#Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,0.38,Rat,,,none,,EH,In Vitro,,Metabolism,set10,1.0,A,Rat,Microsomes,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,N#Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,2.1,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 3,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,N#Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,2.7,CYP2D6,,,uM,,IC50,In Vitro,,CYP Inhibition,set10,1.0,A,CYP2D6,unknown,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,N#Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,15.9,CYP2C19,,,uM,,IC50,In Vitro,,CYP Inhibition,set10,1.0,A,CYP2C19,unknown,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,N#Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,82.0,CACO-2 - pH 7.4/7.4,,,10-6 cm/s,,Papp,In Vitro,,Permeability,set10,1.0,A,CACO-2 - pH 7.4/7.4,A to B,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,N#Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,0.0,T. cruzi,,,%,,Parasitemia clearance after immunosuppression,In Vivo,,"Chagas in vivo at 20 mg/kg, 20 days 2x",set10,1.0,F,T. cruzi,Tulahuen Swiss po,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,N#Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,100.0,T. cruzi,,,%,,Parasitemia clearance after treatment,In Vivo,,"Chagas in vivo at 20 mg/kg, 20 days 2x",set10,1.0,F,T. cruzi,Tulahuen Swiss po,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,N#Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,0.0,T. cruzi,,,%,,PCR cure rate,In Vivo,,"Chagas in vivo at 20 mg/kg, 20 days 2x",set10,1.0,F,T. cruzi,Tulahuen Swiss po,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,N#Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,0.0068,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,N#Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,0.007,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CN(C)S(=O)(=O)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,CN(C)S(=O)(=O)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,0.75,Human,,,none,,EH,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CN(C)S(=O)(=O)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,CN(C)S(=O)(=O)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,3.0,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
CN(C)S(=O)(=O)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,CN(C)S(=O)(=O)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,,PBS - pH 6.5,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10,1.0,A,PBS - pH 6.5,NEPH_RT,ORGANISM,14.0,HEOS,,,,
CN(C)S(=O)(=O)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,CN(C)S(=O)(=O)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,22.0,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CN(C)S(=O)(=O)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,CN(C)S(=O)(=O)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,79.0,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CN(C)S(=O)(=O)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,CN(C)S(=O)(=O)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,2.4,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 3,ORGANISM,14.0,HEOS,,,,
CN(C)S(=O)(=O)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,CN(C)S(=O)(=O)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,10.0,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
CN(C)S(=O)(=O)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,CN(C)S(=O)(=O)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,0.013,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CN(C)S(=O)(=O)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,CN(C)S(=O)(=O)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,0.08700000000000001,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CCS(=O)(=O)N(Cc1cccnc1)c1cccc(-c2nc3ccccc3s2)c1,CCS(=O)(=O)N(Cc1cccnc1)c1cccc(-c2nc3ccccc3s2)c1,.,= ,0.05849999999999999,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CCS(=O)(=O)N(Cc1cccnc1)c1cccc(-c2nc3ccccc3s2)c1,CCS(=O)(=O)N(Cc1cccnc1)c1cccc(-c2nc3ccccc3s2)c1,.,= ,0.023,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CCS(=O)(=O)N(Cc1cccnc1)c1cccc(-c2nc3ccccc3s2)c1,CCS(=O)(=O)N(Cc1cccnc1)c1cccc(-c2nc3ccccc3s2)c1,.,= ,3.2,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 3,ORGANISM,14.0,HEOS,,,,
CCS(=O)(=O)N(Cc1cccnc1)c1cccc(-c2nc3ccccc3s2)c1,CCS(=O)(=O)N(Cc1cccnc1)c1cccc(-c2nc3ccccc3s2)c1,.,= ,346.0,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CCS(=O)(=O)N(Cc1cccnc1)c1cccc(-c2nc3ccccc3s2)c1,CCS(=O)(=O)N(Cc1cccnc1)c1cccc(-c2nc3ccccc3s2)c1,.,= ,5.0,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CCS(=O)(=O)N(Cc1cccnc1)c1cccc(-c2nc3ccccc3s2)c1,CCS(=O)(=O)N(Cc1cccnc1)c1cccc(-c2nc3ccccc3s2)c1,.,= ,,PBS - pH 6.5,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10,1.0,A,PBS - pH 6.5,NEPH_RT,ORGANISM,14.0,HEOS,,,,
CCS(=O)(=O)N(Cc1cccnc1)c1cccc(-c2nc3ccccc3s2)c1,CCS(=O)(=O)N(Cc1cccnc1)c1cccc(-c2nc3ccccc3s2)c1,.,= ,3.6,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
CCS(=O)(=O)N(Cc1cccnc1)c1cccc(-c2nc3ccccc3s2)c1,CCS(=O)(=O)N(Cc1cccnc1)c1cccc(-c2nc3ccccc3s2)c1,.,= ,0.93,Human,,,none,,EH,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CCN(Cc1cccnc1)c1cncc(-c2nc3ccccc3s2)c1,CCN(Cc1cccnc1)c1cncc(-c2nc3ccccc3s2)c1,.,= ,0.3535,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CCN(Cc1cccnc1)c1cncc(-c2nc3ccccc3s2)c1,CCN(Cc1cccnc1)c1cncc(-c2nc3ccccc3s2)c1,.,= ,31.82,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
CCN(Cc1cccnc1)c1cncc(-c2nc3ccccc3s2)c1,CCN(Cc1cccnc1)c1cncc(-c2nc3ccccc3s2)c1,.,= ,0.171,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CCN(Cc1cccnc1)c1cncc(-c2nc3ccccc3s2)c1,CCN(Cc1cccnc1)c1cncc(-c2nc3ccccc3s2)c1,.,= ,0.79,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
CCN(Cc1cccnc1)c1cncc(-c2nc3ccccc3s2)c1,CCN(Cc1cccnc1)c1cncc(-c2nc3ccccc3s2)c1,.,= ,1.56,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 3,ORGANISM,14.0,HEOS,,,,
CCN(Cc1cccnc1)c1cncc(-c2nc3ccccc3s2)c1,CCN(Cc1cccnc1)c1cncc(-c2nc3ccccc3s2)c1,.,= ,414.0,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CCN(Cc1cccnc1)c1cncc(-c2nc3ccccc3s2)c1,CCN(Cc1cccnc1)c1cncc(-c2nc3ccccc3s2)c1,.,= ,4.2,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CCN(Cc1cccnc1)c1cncc(-c2nc3ccccc3s2)c1,CCN(Cc1cccnc1)c1cncc(-c2nc3ccccc3s2)c1,.,= ,3.52,PBS - pH 6.5,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10,1.0,A,PBS - pH 6.5,NEPH_RT,ORGANISM,14.0,HEOS,,,,
CCN(Cc1cccnc1)c1cncc(-c2nc3ccccc3s2)c1,CCN(Cc1cccnc1)c1cncc(-c2nc3ccccc3s2)c1,.,= ,66.31,0.01M HCl - pH 2,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10,1.0,A,0.01M HCl - pH 2,NEPH_RT,ORGANISM,14.0,HEOS,,,,
CCN(Cc1cccnc1)c1cncc(-c2nc3ccccc3s2)c1,CCN(Cc1cccnc1)c1cncc(-c2nc3ccccc3s2)c1,.,= ,3.67,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
CCN(Cc1cccnc1)c1cncc(-c2nc3ccccc3s2)c1,CCN(Cc1cccnc1)c1cncc(-c2nc3ccccc3s2)c1,.,= ,0.953,Human,,,none,,EH,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,21.0,Rat,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10,1.0,A,Rat,Microsomes,ORGANISM,14.0,HEOS,,,,
CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,,T. cruzi,,,%,,% inhibition,In Vivo,,"Chagas in vivo at 20 mg/kg, 20 adm days",set10,1.0,F,T. cruzi,Tulahuen Swiss po,ORGANISM,14.0,HEOS,,,,
CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,80.0,T. cruzi,,,%,,Parasitemia clearance after treatment,In Vivo,,"Chagas in vivo at 20 mg/kg, 20 days 2x",set10,1.0,F,T. cruzi,Tulahuen Swiss po,ORGANISM,14.0,HEOS,,,,
CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,0.55,Human,,,none,,EH,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,3.6,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,,PBS - pH 6.5,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10,1.0,A,PBS - pH 6.5,NEPH_RT,ORGANISM,14.0,HEOS,,,,
CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,54.0,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,32.0,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,2.8,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 3,ORGANISM,14.0,HEOS,,,,
CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,1.0,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,0.00061666666666666,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,0.73,Rat,,,none,,EH,In Vitro,,Metabolism,set10,1.0,A,Rat,Microsomes,ORGANISM,14.0,HEOS,,,,
CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,76.0,Mouse,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10,1.0,A,Mouse,Microsomes,ORGANISM,14.0,HEOS,,,,
CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,0.77,Mouse,,,none,,EH,In Vitro,,Metabolism,set10,1.0,A,Mouse,Microsomes,ORGANISM,14.0,HEOS,,,,
CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,23.0,Mouse,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10,1.0,A,Mouse,Microsomes,ORGANISM,14.0,HEOS,,,,
CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,83.0,Rat,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10,1.0,A,Rat,Microsomes,ORGANISM,14.0,HEOS,,,,
CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,0.0009,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,70.8,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,0.003,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,0.0,T. cruzi,,,%,,PCR cure rate,In Vivo,,"Chagas in vivo at 20 mg/kg, 20 days 2x",set10,1.0,F,T. cruzi,Tulahuen Swiss po,ORGANISM,14.0,HEOS,,,,
CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,20.0,T. cruzi,,,%,,Parasitemia clearance after immunosuppression,In Vivo,,"Chagas in vivo at 20 mg/kg, 20 days 2x",set10,1.0,F,T. cruzi,Tulahuen Swiss po,ORGANISM,14.0,HEOS,,,,
CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,0.002775,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,50.59,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3cccs3)nc2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3cccs3)nc2)c1,.,= ,0.0027,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3cccs3)nc2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3cccs3)nc2)c1,.,= ,0.0095,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3cccs3)nc2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3cccs3)nc2)c1,.,= ,0.8,Human,,,none,,EH,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3cccs3)nc2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3cccs3)nc2)c1,.,= ,3.2,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3cccs3)nc2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3cccs3)nc2)c1,.,= ,,PBS - pH 6.5,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10,1.0,A,PBS - pH 6.5,NEPH_RT,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3cccs3)nc2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3cccs3)nc2)c1,.,= ,17.0,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3cccs3)nc2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3cccs3)nc2)c1,.,= ,102.0,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3cccs3)nc2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3cccs3)nc2)c1,.,= ,2.4,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 3,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3cccs3)nc2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3cccs3)nc2)c1,.,= ,1.4,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccc3)nc2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccc3)nc2)c1,.,= ,0.01304999999999999,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccc3)nc2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccc3)nc2)c1,.,= ,0.0291,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccc3)nc2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccc3)nc2)c1,.,= ,,T. cruzi,,,%,,% inhibition,In Vivo,,"Chagas in vivo at 20 mg/kg, 20 adm days",set10,1.0,F,T. cruzi,Tulahuen Swiss po,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccc3)nc2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccc3)nc2)c1,.,= ,48.6,Rat,,,none,,% bound,In Vitro,,protein binding,set10,1.0,A,Rat,Liver Microsomes,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccc3)nc2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccc3)nc2)c1,.,= ,0.5,Human,,,none,,EH,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccc3)nc2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccc3)nc2)c1,.,= ,0.61,Rat,,,none,,EH,In Vitro,,Metabolism,set10,1.0,A,Rat,Microsomes,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccc3)nc2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccc3)nc2)c1,.,= ,3.3,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccc3)nc2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccc3)nc2)c1,.,= ,0.0245,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccc3)nc2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccc3)nc2)c1,.,= ,0.009,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccc3)nc2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccc3)nc2)c1,.,= ,4.0,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccc3)nc2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccc3)nc2)c1,.,= ,36.0,Rat,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10,1.0,A,Rat,Microsomes,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccc3)nc2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccc3)nc2)c1,.,= ,48.0,Rat,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10,1.0,A,Rat,Microsomes,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccc3)nc2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccc3)nc2)c1,.,= ,2.5,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 3,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccc3)nc2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccc3)nc2)c1,.,= ,53.0,Mouse,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10,1.0,A,Mouse,Microsomes,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccc3)nc2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccc3)nc2)c1,.,= ,0.53,Mouse,,,none,,EH,In Vitro,,Metabolism,set10,1.0,A,Mouse,Microsomes,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccc3)nc2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccc3)nc2)c1,.,= ,26.0,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccc3)nc2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccc3)nc2)c1,.,= ,33.0,Mouse,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10,1.0,A,Mouse,Microsomes,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccc3)nc2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccc3)nc2)c1,.,= ,66.0,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccc3)nc2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccc3)nc2)c1,.,= ,,PBS - pH 6.5,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10,1.0,A,PBS - pH 6.5,NEPH_RT,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccc3)cc2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccc3)cc2)c1,.,= ,3.9,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccc3)cc2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccc3)cc2)c1,.,= ,0.54,Human,,,none,,EH,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccc3)cc2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccc3)cc2)c1,.,= ,0.52,Rat,,,none,,EH,In Vitro,,Metabolism,set10,1.0,A,Rat,Microsomes,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccc3)cc2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccc3)cc2)c1,.,= ,77.8,Rat,,,none,,% bound,In Vitro,,protein binding,set10,1.0,A,Rat,Liver Microsomes,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccc3)cc2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccc3)cc2)c1,.,= ,24.5,Rat,,,mL/min/kg,,CLblood,In Vitro,,Metabolism,set10,1.0,A,Rat,Hepatocytes,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccc3)cc2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccc3)cc2)c1,.,= ,35.0,Rat,,,mL/min/kg,,CLblood,In Vitro,,Metabolism,set10,1.0,A,Rat,Microsomes,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccc3)cc2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccc3)cc2)c1,.,= ,0.065,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccc3)cc2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccc3)cc2)c1,.,= ,0.36,Rat,,,none,,EH,In Vitro,,Metabolism,set10,1.0,A,Rat,Hepatocytes,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccc3)cc2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccc3)cc2)c1,.,= ,0.02039999999999999,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccc3)cc2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccc3)cc2)c1,.,= ,3.0,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccc3)cc2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccc3)cc2)c1,.,= ,40.0,Rat,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10,1.0,A,Rat,Microsomes,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccc3)cc2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccc3)cc2)c1,.,= ,58.0,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccc3)cc2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccc3)cc2)c1,.,= ,31.0,Mouse,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10,1.0,A,Mouse,Microsomes,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccc3)cc2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccc3)cc2)c1,.,= ,30.0,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccc3)cc2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccc3)cc2)c1,.,= ,0.4,Mouse,,,none,,EH,In Vitro,,Metabolism,set10,1.0,A,Mouse,Microsomes,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccc3)cc2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccc3)cc2)c1,.,= ,56.0,Mouse,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10,1.0,A,Mouse,Microsomes,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccc3)cc2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccc3)cc2)c1,.,= ,3.1,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 3,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccc3)cc2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccc3)cc2)c1,.,= ,43.0,Rat,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10,1.0,A,Rat,Microsomes,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccn3)s2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccn3)s2)c1,.,= ,42.0,Rat,,,mL/min/kg,,CLblood,In Vitro,,Metabolism,set10,1.0,A,Rat,Microsomes,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccn3)s2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccn3)s2)c1,.,= ,0.62,Rat,,,none,,EH,In Vitro,,Metabolism,set10,1.0,A,Rat,Microsomes,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccn3)s2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccn3)s2)c1,.,= ,64.0,Rat,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10,1.0,A,Rat,Microsomes,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccn3)s2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccn3)s2)c1,.,= ,27.0,Rat,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10,1.0,A,Rat,Microsomes,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccn3)s2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccn3)s2)c1,.,= ,65.64,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccn3)s2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccn3)s2)c1,.,= ,,T. cruzi,,,%,,% inhibition,In Vivo,,"Chagas in vivo at 20 mg/kg, 20 adm days",set10,1.0,F,T. cruzi,Tulahuen Swiss po,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccn3)s2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccn3)s2)c1,.,= ,63.0,Rat,,,none,,% bound,In Vitro,,protein binding,set10,1.0,A,Rat,Liver Microsomes,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccn3)s2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccn3)s2)c1,.,= ,2.0,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccn3)s2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccn3)s2)c1,.,= ,2.3,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 3,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccn3)s2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccn3)s2)c1,.,= ,30.0,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccn3)s2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccn3)s2)c1,.,= ,0.54,Human,,,none,,EH,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccn3)s2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccn3)s2)c1,.,= ,3.1,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccn3)s2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccn3)s2)c1,.,= ,57.0,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccn3)s2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccn3)s2)c1,.,= ,0.01277499999999999,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccn3)s2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccn3)s2)c1,.,= ,72.46,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccn3)s2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccn3)s2)c1,.,= ,0.006625,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccn3)s2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2ccc(-c3ccccn3)s2)c1,.,= ,,PBS - pH 6.5,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10,1.0,A,PBS - pH 6.5,NEPH_RT,ORGANISM,14.0,HEOS,,,,
O=C(C1CC1)N(Cc1cccnc1)c1cncc(-c2nc3ccccc3s2)c1,O=C(C1CC1)N(Cc1cccnc1)c1cncc(-c2nc3ccccc3s2)c1,.,= ,0.948,Human,,,none,,EH,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
O=C(C1CC1)N(Cc1cccnc1)c1cncc(-c2nc3ccccc3s2)c1,O=C(C1CC1)N(Cc1cccnc1)c1cncc(-c2nc3ccccc3s2)c1,.,= ,3.25,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
O=C(C1CC1)N(Cc1cccnc1)c1cncc(-c2nc3ccccc3s2)c1,O=C(C1CC1)N(Cc1cccnc1)c1cncc(-c2nc3ccccc3s2)c1,.,= ,0.034,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
O=C(C1CC1)N(Cc1cccnc1)c1cncc(-c2nc3ccccc3s2)c1,O=C(C1CC1)N(Cc1cccnc1)c1cncc(-c2nc3ccccc3s2)c1,.,= ,0.0129,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
O=C(C1CC1)N(Cc1cccnc1)c1cncc(-c2nc3ccccc3s2)c1,O=C(C1CC1)N(Cc1cccnc1)c1cncc(-c2nc3ccccc3s2)c1,.,= ,1.12,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
O=C(C1CC1)N(Cc1cccnc1)c1cncc(-c2nc3ccccc3s2)c1,O=C(C1CC1)N(Cc1cccnc1)c1cncc(-c2nc3ccccc3s2)c1,.,= ,1.9,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 3,ORGANISM,14.0,HEOS,,,,
O=C(C1CC1)N(Cc1cccnc1)c1cncc(-c2nc3ccccc3s2)c1,O=C(C1CC1)N(Cc1cccnc1)c1cncc(-c2nc3ccccc3s2)c1,.,= ,371.5,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
O=C(C1CC1)N(Cc1cccnc1)c1cncc(-c2nc3ccccc3s2)c1,O=C(C1CC1)N(Cc1cccnc1)c1cncc(-c2nc3ccccc3s2)c1,.,= ,21.66,PBS - pH 6.5,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10,1.0,A,PBS - pH 6.5,NEPH_RT,ORGANISM,14.0,HEOS,,,,
O=C(C1CC1)N(Cc1cccnc1)c1cncc(-c2nc3ccccc3s2)c1,O=C(C1CC1)N(Cc1cccnc1)c1cncc(-c2nc3ccccc3s2)c1,.,= ,4.7,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnn(-c3ccccn3)c2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnn(-c3ccccn3)c2)c1,.,= ,97.8,mouse,,,%,,% bound,In Vitro,,protein binding,set10,1.0,A,mouse,plasma,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnn(-c3ccccn3)c2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnn(-c3ccccn3)c2)c1,.,= ,0.0067,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnn(-c3ccccn3)c2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnn(-c3ccccn3)c2)c1,.,= ,0.006,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnn(-c3ccccn3)c2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnn(-c3ccccn3)c2)c1,.,= ,0.51,Rat,,,none,,EH,In Vitro,,Metabolism,set10,1.0,A,Rat,Hepatocytes,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnn(-c3ccccn3)c2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnn(-c3ccccn3)c2)c1,.,= ,99.2,rat,,,%,,% bound,In Vitro,,protein binding,set10,1.0,A,rat,plasma,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnn(-c3ccccn3)c2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnn(-c3ccccn3)c2)c1,.,= ,0.016,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnn(-c3ccccn3)c2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnn(-c3ccccn3)c2)c1,.,= ,0.014,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnn(-c3ccccn3)c2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnn(-c3ccccn3)c2)c1,.,= ,0.0,T. cruzi,,,%,,PCR cure rate,In Vivo,,"Chagas in vivo at 20 mg/kg, 20 days 1x",set10,1.0,F,T. cruzi,Tulahuen Swiss po,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnn(-c3ccccn3)c2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnn(-c3ccccn3)c2)c1,.,= ,0.0,T. cruzi,,,%,,PCR cure rate,In Vivo,,"Chagas in vivo at 50 mg/kg, 20 days 1x",set10,1.0,F,T. cruzi,Tulahuen Swiss po,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnn(-c3ccccn3)c2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnn(-c3ccccn3)c2)c1,.,= ,0.0,T. cruzi,,,%,,Parasitemia clearance after immunosuppression,In Vivo,,"Chagas in vivo at 20 mg/kg, 20 days 1x",set10,1.0,F,T. cruzi,Tulahuen Swiss po,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnn(-c3ccccn3)c2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnn(-c3ccccn3)c2)c1,.,= ,0.0,T. cruzi,,,%,,Parasitemia clearance after immunosuppression,In Vivo,,"Chagas in vivo at 50 mg/kg, 20 days 1x",set10,1.0,F,T. cruzi,Tulahuen Swiss po,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnn(-c3ccccn3)c2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnn(-c3ccccn3)c2)c1,.,= ,0.0,T. cruzi,,,%,,PCR cure rate,In Vivo,,"Chagas in vivo at 20 mg/kg, 20 days 2x",set10,1.0,F,T. cruzi,Tulahuen Swiss po,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnn(-c3ccccn3)c2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnn(-c3ccccn3)c2)c1,.,= ,0.0,T. cruzi,,,%,,Parasitemia clearance after immunosuppression,In Vivo,,"Chagas in vivo at 20 mg/kg, 20 days 2x",set10,1.0,F,T. cruzi,Tulahuen Swiss po,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnn(-c3ccccn3)c2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnn(-c3ccccn3)c2)c1,.,= ,0.0,T. cruzi,,,%,,Parasitemia clearance after treatment,In Vivo,,"Chagas in vivo at 20 mg/kg, 20 days 1x",set10,1.0,F,T. cruzi,Tulahuen Swiss po,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnn(-c3ccccn3)c2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnn(-c3ccccn3)c2)c1,.,= ,20.0,T. cruzi,,,%,,Parasitemia clearance after treatment,In Vivo,,"Chagas in vivo at 50 mg/kg, 20 days 1x",set10,1.0,F,T. cruzi,Tulahuen Swiss po,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnn(-c3ccccn3)c2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnn(-c3ccccn3)c2)c1,.,= ,80.0,T. cruzi,,,%,,Parasitemia clearance after treatment,In Vivo,,"Chagas in vivo at 20 mg/kg, 20 days 2x",set10,1.0,F,T. cruzi,Tulahuen Swiss po,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnn(-c3ccccn3)c2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnn(-c3ccccn3)c2)c1,.,= ,34.3,Rat,,,mL/min/kg,,CLblood,In Vitro,,Metabolism,set10,1.0,A,Rat,Hepatocytes,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnn(-c3ccccn3)c2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnn(-c3ccccn3)c2)c1,.,= ,35.6,Rat,,,none,,% bound,In Vitro,,protein binding,set10,1.0,A,Rat,Liver Microsomes,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnn(-c3ccccn3)c2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnn(-c3ccccn3)c2)c1,.,= ,0.38,Human,,,none,,EH,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnn(-c3ccccn3)c2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnn(-c3ccccn3)c2)c1,.,= ,0.47,Rat,,,none,,EH,In Vitro,,Metabolism,set10,1.0,A,Rat,Microsomes,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnn(-c3ccccn3)c2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnn(-c3ccccn3)c2)c1,.,= ,108.0,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnn(-c3ccccn3)c2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnn(-c3ccccn3)c2)c1,.,= ,83.0,Mouse,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10,1.0,A,Mouse,Microsomes,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnn(-c3ccccn3)c2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnn(-c3ccccn3)c2)c1,.,= ,16.0,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnn(-c3ccccn3)c2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnn(-c3ccccn3)c2)c1,.,= ,0.78,Mouse,,,none,,EH,In Vitro,,Metabolism,set10,1.0,A,Mouse,Microsomes,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnn(-c3ccccn3)c2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnn(-c3ccccn3)c2)c1,.,= ,21.0,Mouse,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10,1.0,A,Mouse,Microsomes,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnn(-c3ccccn3)c2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnn(-c3ccccn3)c2)c1,.,= ,27.0,Rat,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10,1.0,A,Rat,Microsomes,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnn(-c3ccccn3)c2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnn(-c3ccccn3)c2)c1,.,= ,64.0,Rat,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10,1.0,A,Rat,Microsomes,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnn(-c3ccccn3)c2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnn(-c3ccccn3)c2)c1,.,= ,1.4,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
CC(=O)N(Cc1cccnc1)c1ccc(-c2nc3ccccc3s2)cc1,CC(=O)N(Cc1cccnc1)c1ccc(-c2nc3ccccc3s2)cc1,.,= ,98.3,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CC(=O)N(Cc1cccnc1)c1ccc(-c2nc3ccccc3s2)cc1,CC(=O)N(Cc1cccnc1)c1ccc(-c2nc3ccccc3s2)cc1,.,= ,2.18,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 3,ORGANISM,14.0,HEOS,,,,
CC(=O)N(Cc1cccnc1)c1ccc(-c2nc3ccccc3s2)cc1,CC(=O)N(Cc1cccnc1)c1ccc(-c2nc3ccccc3s2)cc1,.,= ,72.0,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CC(=O)N(Cc1cccnc1)c1ccc(-c2nc3ccccc3s2)cc1,CC(=O)N(Cc1cccnc1)c1ccc(-c2nc3ccccc3s2)cc1,.,= ,17.6,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CC(=O)N(Cc1cccnc1)c1ccc(-c2nc3ccccc3s2)cc1,CC(=O)N(Cc1cccnc1)c1ccc(-c2nc3ccccc3s2)cc1,.,= ,24.0,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CC(=O)N(Cc1cccnc1)c1ccc(-c2nc3ccccc3s2)cc1,CC(=O)N(Cc1cccnc1)c1ccc(-c2nc3ccccc3s2)cc1,.,= ,11.87,PBS - pH 6.5,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10,1.0,A,PBS - pH 6.5,NEPH_RT,ORGANISM,14.0,HEOS,,,,
CC(=O)N(Cc1cccnc1)c1ccc(-c2nc3ccccc3s2)cc1,CC(=O)N(Cc1cccnc1)c1ccc(-c2nc3ccccc3s2)cc1,.,= ,71.05,0.01M HCl - pH 2,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10,1.0,A,0.01M HCl - pH 2,NEPH_RT,ORGANISM,14.0,HEOS,,,,
CC(=O)N(Cc1cccnc1)c1ccc(-c2nc3ccccc3s2)cc1,CC(=O)N(Cc1cccnc1)c1ccc(-c2nc3ccccc3s2)cc1,.,= ,2.9,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
CC(=O)N(Cc1cccnc1)c1ccc(-c2nc3ccccc3s2)cc1,CC(=O)N(Cc1cccnc1)c1ccc(-c2nc3ccccc3s2)cc1,.,= ,1.52,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
CC(=O)N(Cc1cccnc1)c1ccc(-c2nc3ccccc3s2)cc1,CC(=O)N(Cc1cccnc1)c1ccc(-c2nc3ccccc3s2)cc1,.,= ,0.829,Human,,,none,,EH,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CC(=O)N(Cc1cccnc1)c1ccc(-c2nc3ccccc3s2)cc1,CC(=O)N(Cc1cccnc1)c1ccc(-c2nc3ccccc3s2)cc1,.,= ,0.74,Human,,,none,,EH,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CCS(=O)(=O)N(Cc1cccnc1)c1cncc(-c2nc3ccccc3s2)c1,CCS(=O)(=O)N(Cc1cccnc1)c1cncc(-c2nc3ccccc3s2)c1,.,= ,3.19,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
CCS(=O)(=O)N(Cc1cccnc1)c1cncc(-c2nc3ccccc3s2)c1,CCS(=O)(=O)N(Cc1cccnc1)c1cncc(-c2nc3ccccc3s2)c1,.,= ,0.965,Human,,,none,,EH,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CCS(=O)(=O)N(Cc1cccnc1)c1cncc(-c2nc3ccccc3s2)c1,CCS(=O)(=O)N(Cc1cccnc1)c1cncc(-c2nc3ccccc3s2)c1,.,= ,0.35500000000000004,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CCS(=O)(=O)N(Cc1cccnc1)c1cncc(-c2nc3ccccc3s2)c1,CCS(=O)(=O)N(Cc1cccnc1)c1cncc(-c2nc3ccccc3s2)c1,.,= ,0.0135,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CCS(=O)(=O)N(Cc1cccnc1)c1cncc(-c2nc3ccccc3s2)c1,CCS(=O)(=O)N(Cc1cccnc1)c1cncc(-c2nc3ccccc3s2)c1,.,= ,1.04,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
CCS(=O)(=O)N(Cc1cccnc1)c1cncc(-c2nc3ccccc3s2)c1,CCS(=O)(=O)N(Cc1cccnc1)c1cncc(-c2nc3ccccc3s2)c1,.,= ,1.89,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 3,ORGANISM,14.0,HEOS,,,,
CCS(=O)(=O)N(Cc1cccnc1)c1cncc(-c2nc3ccccc3s2)c1,CCS(=O)(=O)N(Cc1cccnc1)c1cncc(-c2nc3ccccc3s2)c1,.,= ,558.8,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CCS(=O)(=O)N(Cc1cccnc1)c1cncc(-c2nc3ccccc3s2)c1,CCS(=O)(=O)N(Cc1cccnc1)c1cncc(-c2nc3ccccc3s2)c1,.,= ,3.1,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CCS(=O)(=O)N(Cc1cccnc1)c1cncc(-c2nc3ccccc3s2)c1,CCS(=O)(=O)N(Cc1cccnc1)c1cncc(-c2nc3ccccc3s2)c1,.,= ,13.04,PBS - pH 6.5,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10,1.0,A,PBS - pH 6.5,NEPH_RT,ORGANISM,14.0,HEOS,,,,
O=C(Nc1ccccc1-n1ccnc1)c1cnc(-c2ccccc2)s1,O=C(Nc1ccccc1-n1ccnc1)c1cnc(-c2ccccc2)s1,.,= ,0.69,Human,,,none,,EH,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
O=C(Nc1ccccc1-n1ccnc1)c1cnc(-c2ccccc2)s1,O=C(Nc1ccccc1-n1ccnc1)c1cnc(-c2ccccc2)s1,.,= ,2.5,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
O=C(Nc1ccccc1-n1ccnc1)c1cnc(-c2ccccc2)s1,O=C(Nc1ccccc1-n1ccnc1)c1cnc(-c2ccccc2)s1,.,= ,,PBS - pH 6.5,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10,1.0,A,PBS - pH 6.5,NEPH_RT,ORGANISM,14.0,HEOS,,,,
O=C(Nc1ccccc1-n1ccnc1)c1cnc(-c2ccccc2)s1,O=C(Nc1ccccc1-n1ccnc1)c1cnc(-c2ccccc2)s1,.,= ,30.0,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
O=C(Nc1ccccc1-n1ccnc1)c1cnc(-c2ccccc2)s1,O=C(Nc1ccccc1-n1ccnc1)c1cnc(-c2ccccc2)s1,.,= ,57.0,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
O=C(Nc1ccccc1-n1ccnc1)c1cnc(-c2ccccc2)s1,O=C(Nc1ccccc1-n1ccnc1)c1cnc(-c2ccccc2)s1,.,= ,1.4,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 3,ORGANISM,14.0,HEOS,,,,
O=C(Nc1ccccc1-n1ccnc1)c1cnc(-c2ccccc2)s1,O=C(Nc1ccccc1-n1ccnc1)c1cnc(-c2ccccc2)s1,.,= ,2.0,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
O=C(Nc1ccccc1-n1ccnc1)c1cnc(-c2ccccc2)s1,O=C(Nc1ccccc1-n1ccnc1)c1cnc(-c2ccccc2)s1,.,= ,0.0049,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
O=C(Nc1ccccc1-n1ccnc1)c1cnc(-c2ccccc2)s1,O=C(Nc1ccccc1-n1ccnc1)c1cnc(-c2ccccc2)s1,.,= ,0.0032,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
O=C(Nc1ccccc1-n1ccnc1)c1cnc(-c2ccccc2)s1,O=C(Nc1ccccc1-n1ccnc1)c1cnc(-c2ccccc2)s1,.,= ,0.0038,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
O=C(Nc1ccccc1-n1ccnc1)c1cnc(-c2ccccc2)s1,O=C(Nc1ccccc1-n1ccnc1)c1cnc(-c2ccccc2)s1,.,= ,45.0,CYP3A4,,,%,,% inhibition,In Vitro,,CYP Inhibition at 1 uM,set10,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
O=C(Nc1ccccc1-n1ccnc1)c1cnc(-c2ccccc2)s1,O=C(Nc1ccccc1-n1ccnc1)c1cnc(-c2ccccc2)s1,.,= ,0.01,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
O=C(Nc1ccccc1-n1ccnc1)c1cnc(-c2ccccc2)s1,O=C(Nc1ccccc1-n1ccnc1)c1cnc(-c2ccccc2)s1,.,= ,0.00999999999999999,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
O=C(Nc1ccccc1-n1ccnc1)c1cnc(-c2ccccc2)s1,O=C(Nc1ccccc1-n1ccnc1)c1cnc(-c2ccccc2)s1,.,= ,86.0,CYP3A4,,,%,,% inhibition,In Vitro,,CYP Inhibition at 10 uM,set10,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
O=C(Nc1ccccc1-n1ccnc1)c1cnc(-c2ccccc2)nc1,O=C(Nc1ccccc1-n1ccnc1)c1cnc(-c2ccccc2)nc1,.,= ,0.1485,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
O=C(Nc1ccccc1-n1ccnc1)c1cnc(-c2ccccc2)nc1,O=C(Nc1ccccc1-n1ccnc1)c1cnc(-c2ccccc2)nc1,.,= ,27.0,CYP3A4,,,%,,% inhibition,In Vitro,,CYP Inhibition at 10 uM,set10,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
O=C(Nc1ccccc1-n1ccnc1)c1cnc(-c2ccccc2)nc1,O=C(Nc1ccccc1-n1ccnc1)c1cnc(-c2ccccc2)nc1,.,= ,,CYP3A4,,,%,,% inhibition,In Vitro,,CYP Inhibition at 1 uM,set10,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
O=C(Nc1ccccc1-n1ccnc1)c1cnc(-c2ccccc2)nc1,O=C(Nc1ccccc1-n1ccnc1)c1cnc(-c2ccccc2)nc1,.,= ,0.063,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
O=C(Nc1ccccc1-n1ccnc1)c1cnc(-c2ccccc2)nc1,O=C(Nc1ccccc1-n1ccnc1)c1cnc(-c2ccccc2)nc1,.,= ,1.3,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 3,ORGANISM,14.0,HEOS,,,,
O=C(Nc1ccccc1-n1ccnc1)c1cnc(-c2ccccc2)nc1,O=C(Nc1ccccc1-n1ccnc1)c1cnc(-c2ccccc2)nc1,.,= ,18.0,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
O=C(Nc1ccccc1-n1ccnc1)c1cnc(-c2ccccc2)nc1,O=C(Nc1ccccc1-n1ccnc1)c1cnc(-c2ccccc2)nc1,.,= ,99.0,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
O=C(Nc1ccccc1-n1ccnc1)c1cnc(-c2ccccc2)nc1,O=C(Nc1ccccc1-n1ccnc1)c1cnc(-c2ccccc2)nc1,.,= ,,PBS - pH 6.5,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10,1.0,A,PBS - pH 6.5,NEPH_RT,ORGANISM,14.0,HEOS,,,,
O=C(Nc1ccccc1-n1ccnc1)c1cnc(-c2ccccc2)nc1,O=C(Nc1ccccc1-n1ccnc1)c1cnc(-c2ccccc2)nc1,.,= ,2.4,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
O=C(Nc1ccccc1-n1ccnc1)c1cnc(-c2ccccc2)nc1,O=C(Nc1ccccc1-n1ccnc1)c1cnc(-c2ccccc2)nc1,.,= ,0.4,Human,,,none,,EH,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cc(-c3ccccc3)cs2)c1,CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cc(-c3ccccc3)cs2)c1,.,= ,0.011,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cc(-c3ccccc3)cs2)c1,CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cc(-c3ccccc3)cs2)c1,.,= ,0.021,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cc(-c3ccccc3)cs2)c1,CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cc(-c3ccccc3)cs2)c1,.,= ,0.015,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cc(-c3ccccc3)cs2)c1,CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cc(-c3ccccc3)cs2)c1,.,= ,0.014,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cc(-c3ccccc3)cs2)c1,CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cc(-c3ccccc3)cs2)c1,.,= ,0.033,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cc(-c3ccccc3)cs2)c1,CON=C(C)c1ccc(-n2ccnc2)c(NC(=O)c2cc(-c3ccccc3)cs2)c1,.,= ,0.031,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CCN(Cc1cccnc1)c1cc(F)cc(-c2nc3ccccc3s2)c1,CCN(Cc1cccnc1)c1cc(F)cc(-c2nc3ccccc3s2)c1,.,= ,0.098,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CCN(Cc1cccnc1)c1cc(F)cc(-c2nc3ccccc3s2)c1,CCN(Cc1cccnc1)c1cc(F)cc(-c2nc3ccccc3s2)c1,.,= ,57.74,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
CCN(Cc1cccnc1)c1cc(F)cc(-c2nc3ccccc3s2)c1,CCN(Cc1cccnc1)c1cc(F)cc(-c2nc3ccccc3s2)c1,.,= ,0.047,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CCN(Cc1cccnc1)c1cc(F)cc(-c2nc3ccccc3s2)c1,CCN(Cc1cccnc1)c1cc(F)cc(-c2nc3ccccc3s2)c1,.,= ,0.775,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
CCN(Cc1cccnc1)c1cc(F)cc(-c2nc3ccccc3s2)c1,CCN(Cc1cccnc1)c1cc(F)cc(-c2nc3ccccc3s2)c1,.,= ,3.75,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 3,ORGANISM,14.0,HEOS,,,,
CCN(Cc1cccnc1)c1cc(F)cc(-c2nc3ccccc3s2)c1,CCN(Cc1cccnc1)c1cc(F)cc(-c2nc3ccccc3s2)c1,.,= ,178.8,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CCN(Cc1cccnc1)c1cc(F)cc(-c2nc3ccccc3s2)c1,CCN(Cc1cccnc1)c1cc(F)cc(-c2nc3ccccc3s2)c1,.,= ,9.7,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CCN(Cc1cccnc1)c1cc(F)cc(-c2nc3ccccc3s2)c1,CCN(Cc1cccnc1)c1cc(F)cc(-c2nc3ccccc3s2)c1,.,= ,57.2,0.01M HCl - pH 2,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10,1.0,A,0.01M HCl - pH 2,NEPH_RT,ORGANISM,14.0,HEOS,,,,
CCN(Cc1cccnc1)c1cc(F)cc(-c2nc3ccccc3s2)c1,CCN(Cc1cccnc1)c1cc(F)cc(-c2nc3ccccc3s2)c1,.,= ,0.898,Human,,,none,,EH,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
O=C(C1CC1)N(Cc1cccnc1)c1cc(F)cc(-c2nc3ccccc3s2)c1,O=C(C1CC1)N(Cc1cccnc1)c1cc(F)cc(-c2nc3ccccc3s2)c1,.,= ,0.985,Human,,,none,,EH,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
O=C(C1CC1)N(Cc1cccnc1)c1cc(F)cc(-c2nc3ccccc3s2)c1,O=C(C1CC1)N(Cc1cccnc1)c1cc(F)cc(-c2nc3ccccc3s2)c1,.,= ,4.49,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
O=C(C1CC1)N(Cc1cccnc1)c1cc(F)cc(-c2nc3ccccc3s2)c1,O=C(C1CC1)N(Cc1cccnc1)c1cc(F)cc(-c2nc3ccccc3s2)c1,.,= ,6.65,PBS - pH 6.5,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10,1.0,A,PBS - pH 6.5,NEPH_RT,ORGANISM,14.0,HEOS,,,,
O=C(C1CC1)N(Cc1cccnc1)c1cc(F)cc(-c2nc3ccccc3s2)c1,O=C(C1CC1)N(Cc1cccnc1)c1cc(F)cc(-c2nc3ccccc3s2)c1,.,= ,1.3,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
O=C(C1CC1)N(Cc1cccnc1)c1cc(F)cc(-c2nc3ccccc3s2)c1,O=C(C1CC1)N(Cc1cccnc1)c1cc(F)cc(-c2nc3ccccc3s2)c1,.,= ,1324.5,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
O=C(C1CC1)N(Cc1cccnc1)c1cc(F)cc(-c2nc3ccccc3s2)c1,O=C(C1CC1)N(Cc1cccnc1)c1cc(F)cc(-c2nc3ccccc3s2)c1,.,= ,3.04,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 3,ORGANISM,14.0,HEOS,,,,
O=C(C1CC1)N(Cc1cccnc1)c1cc(F)cc(-c2nc3ccccc3s2)c1,O=C(C1CC1)N(Cc1cccnc1)c1cc(F)cc(-c2nc3ccccc3s2)c1,.,= ,1.11,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
O=C(C1CC1)N(Cc1cccnc1)c1cc(F)cc(-c2nc3ccccc3s2)c1,O=C(C1CC1)N(Cc1cccnc1)c1cc(F)cc(-c2nc3ccccc3s2)c1,.,= ,0.02,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
O=C(C1CC1)N(Cc1cccnc1)c1cc(F)cc(-c2nc3ccccc3s2)c1,O=C(C1CC1)N(Cc1cccnc1)c1cc(F)cc(-c2nc3ccccc3s2)c1,.,= ,76.87,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
O=C(C1CC1)N(Cc1cccnc1)c1cc(F)cc(-c2nc3ccccc3s2)c1,O=C(C1CC1)N(Cc1cccnc1)c1cc(F)cc(-c2nc3ccccc3s2)c1,.,= ,0.0625,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
O=C(C1CC1)N(Cc1cccnc1)c1cc(F)cc(-c2nc3ccccc3s2)c1,O=C(C1CC1)N(Cc1cccnc1)c1cc(F)cc(-c2nc3ccccc3s2)c1,.,= ,66.87,0.01M HCl - pH 2,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10,1.0,A,0.01M HCl - pH 2,NEPH_RT,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2sc(-c3ccccc3)nc2C)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2sc(-c3ccccc3)nc2C)c1,.,= ,0.2035,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2sc(-c3ccccc3)nc2C)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2sc(-c3ccccc3)nc2C)c1,.,= ,96.0,CYP3A4,,,%,,% inhibition,In Vitro,,CYP Inhibition at 10 uM,set10,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2sc(-c3ccccc3)nc2C)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2sc(-c3ccccc3)nc2C)c1,.,= ,88.0,CYP3A4,,,%,,% inhibition,In Vitro,,CYP Inhibition at 1 uM,set10,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2sc(-c3ccccc3)nc2C)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2sc(-c3ccccc3)nc2C)c1,.,= ,0.0675,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2sc(-c3ccccc3)nc2C)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2sc(-c3ccccc3)nc2C)c1,.,= ,2.3,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 3,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2sc(-c3ccccc3)nc2C)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2sc(-c3ccccc3)nc2C)c1,.,= ,0.41,Human,,,none,,EH,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2sc(-c3ccccc3)nc2C)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2sc(-c3ccccc3)nc2C)c1,.,= ,18.0,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2sc(-c3ccccc3)nc2C)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2sc(-c3ccccc3)nc2C)c1,.,= ,97.0,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2sc(-c3ccccc3)nc2C)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2sc(-c3ccccc3)nc2C)c1,.,= ,,PBS - pH 6.5,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10,1.0,A,PBS - pH 6.5,NEPH_RT,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2sc(-c3ccccc3)nc2C)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2sc(-c3ccccc3)nc2C)c1,.,= ,3.5,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
Cl.NCC(=O)N(Cc1cccnc1)c1cc(F)cc(-c2nc3ccccc3s2)c1,NCC(=O)N(Cc1cccnc1)c1cc(F)cc(-c2nc3ccccc3s2)c1,Cl,= ,58.0,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
Cl.NCC(=O)N(Cc1cccnc1)c1cc(F)cc(-c2nc3ccccc3s2)c1,NCC(=O)N(Cc1cccnc1)c1cc(F)cc(-c2nc3ccccc3s2)c1,Cl,= ,66.0,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
Cl.NCC(=O)N(Cc1cccnc1)c1cc(F)cc(-c2nc3ccccc3s2)c1,NCC(=O)N(Cc1cccnc1)c1cc(F)cc(-c2nc3ccccc3s2)c1,Cl,= ,0.766,Human,,,none,,EH,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
Cl.NCC(=O)N(Cc1cccnc1)c1cc(F)cc(-c2nc3ccccc3s2)c1,NCC(=O)N(Cc1cccnc1)c1cc(F)cc(-c2nc3ccccc3s2)c1,Cl,= ,0.54,Human,,,none,,EH,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
Cl.NCC(=O)N(Cc1cccnc1)c1cc(F)cc(-c2nc3ccccc3s2)c1,NCC(=O)N(Cc1cccnc1)c1cc(F)cc(-c2nc3ccccc3s2)c1,Cl,= ,2.29,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
Cl.NCC(=O)N(Cc1cccnc1)c1cc(F)cc(-c2nc3ccccc3s2)c1,NCC(=O)N(Cc1cccnc1)c1cc(F)cc(-c2nc3ccccc3s2)c1,Cl,= ,2.2,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
Cl.NCC(=O)N(Cc1cccnc1)c1cc(F)cc(-c2nc3ccccc3s2)c1,NCC(=O)N(Cc1cccnc1)c1cc(F)cc(-c2nc3ccccc3s2)c1,Cl,= ,57.52,0.01M HCl - pH 2,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10,1.0,A,0.01M HCl - pH 2,NEPH_RT,ORGANISM,14.0,HEOS,,,,
Cl.NCC(=O)N(Cc1cccnc1)c1cc(F)cc(-c2nc3ccccc3s2)c1,NCC(=O)N(Cc1cccnc1)c1cc(F)cc(-c2nc3ccccc3s2)c1,Cl,= ,0.125,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
Cl.NCC(=O)N(Cc1cccnc1)c1cc(F)cc(-c2nc3ccccc3s2)c1,NCC(=O)N(Cc1cccnc1)c1cc(F)cc(-c2nc3ccccc3s2)c1,Cl,= ,85.8,CYP3A4,,,%,,% inhibition,In Vitro,,CYP Inhibition at 10 uM,set10,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
Cl.NCC(=O)N(Cc1cccnc1)c1cc(F)cc(-c2nc3ccccc3s2)c1,NCC(=O)N(Cc1cccnc1)c1cc(F)cc(-c2nc3ccccc3s2)c1,Cl,= ,30.0,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
Cl.NCC(=O)N(Cc1cccnc1)c1cc(F)cc(-c2nc3ccccc3s2)c1,NCC(=O)N(Cc1cccnc1)c1cc(F)cc(-c2nc3ccccc3s2)c1,Cl,= ,-0.54,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 3,ORGANISM,14.0,HEOS,,,,
Cl.NCC(=O)N(Cc1cccnc1)c1cc(F)cc(-c2nc3ccccc3s2)c1,NCC(=O)N(Cc1cccnc1)c1cc(F)cc(-c2nc3ccccc3s2)c1,Cl,= ,1.3,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 3,ORGANISM,14.0,HEOS,,,,
Cl.NCC(=O)N(Cc1cccnc1)c1cc(F)cc(-c2nc3ccccc3s2)c1,NCC(=O)N(Cc1cccnc1)c1cc(F)cc(-c2nc3ccccc3s2)c1,Cl,= ,1.01,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
Cl.NCC(=O)N(Cc1cccnc1)c1cc(F)cc(-c2nc3ccccc3s2)c1,NCC(=O)N(Cc1cccnc1)c1cc(F)cc(-c2nc3ccccc3s2)c1,Cl,= ,0.049,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
Cl.NCC(=O)N(Cc1cccnc1)c1cc(F)cc(-c2nc3ccccc3s2)c1,NCC(=O)N(Cc1cccnc1)c1cc(F)cc(-c2nc3ccccc3s2)c1,Cl,= ,51.8,CYP3A4,,,%,,% inhibition,In Vitro,,CYP Inhibition at 1 uM,set10,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
Cl.NCC(=O)N(Cc1cccnc1)c1cc(F)cc(-c2nc3ccccc3s2)c1,NCC(=O)N(Cc1cccnc1)c1cc(F)cc(-c2nc3ccccc3s2)c1,Cl,= ,53.02,PBS - pH 6.5,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10,1.0,A,PBS - pH 6.5,NEPH_RT,ORGANISM,14.0,HEOS,,,,
Cl.NCC(=O)N(Cc1cccnc1)c1cc(F)cc(-c2nc3ccccc3s2)c1,NCC(=O)N(Cc1cccnc1)c1cc(F)cc(-c2nc3ccccc3s2)c1,Cl,= ,26.3,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)N(Cc1cccnc1)c1ccc(-c2nc3ccccc3s2)cc1,CS(=O)(=O)N(Cc1cccnc1)c1ccc(-c2nc3ccccc3s2)cc1,.,= ,0.091,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)N(Cc1cccnc1)c1ccc(-c2nc3ccccc3s2)cc1,CS(=O)(=O)N(Cc1cccnc1)c1ccc(-c2nc3ccccc3s2)cc1,.,= ,0.04049999999999999,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CCN(Cc1cccnc1)c1ccc(-c2nc3ccccc3s2)cc1,CCN(Cc1cccnc1)c1ccc(-c2nc3ccccc3s2)cc1,.,= ,0.35050000000000003,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CCN(Cc1cccnc1)c1ccc(-c2nc3ccccc3s2)cc1,CCN(Cc1cccnc1)c1ccc(-c2nc3ccccc3s2)cc1,.,= ,54.49,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
CCN(Cc1cccnc1)c1ccc(-c2nc3ccccc3s2)cc1,CCN(Cc1cccnc1)c1ccc(-c2nc3ccccc3s2)cc1,.,= ,0.632,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CCN(Cc1cccnc1)c1ccc(-c2ccc(F)cc2)cc1F,CCN(Cc1cccnc1)c1ccc(-c2ccc(F)cc2)cc1F,.,= ,21.5,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CCN(Cc1cccnc1)c1ccc(-c2ccc(F)cc2)cc1F,CCN(Cc1cccnc1)c1ccc(-c2ccc(F)cc2)cc1F,.,= ,80.5,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CCN(Cc1cccnc1)c1ccc(-c2ccc(F)cc2)cc1F,CCN(Cc1cccnc1)c1ccc(-c2ccc(F)cc2)cc1F,.,= ,0.799,Human,,,none,,EH,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CCN(Cc1cccnc1)c1ccc(-c2ccc(F)cc2)cc1F,CCN(Cc1cccnc1)c1ccc(-c2ccc(F)cc2)cc1F,.,= ,3.49,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 3,ORGANISM,14.0,HEOS,,,,
CCN(Cc1cccnc1)c1ccc(-c2ccc(F)cc2)cc1F,CCN(Cc1cccnc1)c1ccc(-c2ccc(F)cc2)cc1F,.,= ,1.0,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
CCN(Cc1cccnc1)c1ccc(-c2ccc(F)cc2)cc1F,CCN(Cc1cccnc1)c1ccc(-c2ccc(F)cc2)cc1F,.,= ,0.0825,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CCN(Cc1cccnc1)c1ccc(-c2ccc(F)cc2)cc1F,CCN(Cc1cccnc1)c1ccc(-c2ccc(F)cc2)cc1F,.,= ,59.52,0.01M HCl - pH 2,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10,1.0,A,0.01M HCl - pH 2,NEPH_RT,ORGANISM,14.0,HEOS,,,,
CCN(Cc1cccnc1)c1ccc(-c2ccc(F)cc2)cc1F,CCN(Cc1cccnc1)c1ccc(-c2ccc(F)cc2)cc1F,.,= ,56.27,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
CCN(Cc1cccnc1)c1ccc(-c2ccc(F)cc2)cc1F,CCN(Cc1cccnc1)c1ccc(-c2ccc(F)cc2)cc1F,.,= ,0.017,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CC(=O)N(Cc1cccnc1)c1ccc(-c2ccc(F)cc2)cc1F,CC(=O)N(Cc1cccnc1)c1ccc(-c2ccc(F)cc2)cc1F,.,= ,0.1835,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CC(=O)N(Cc1cccnc1)c1ccc(-c2ccc(F)cc2)cc1F,CC(=O)N(Cc1cccnc1)c1ccc(-c2ccc(F)cc2)cc1F,.,= ,71.8,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
CC(=O)N(Cc1cccnc1)c1ccc(-c2ccc(F)cc2)cc1F,CC(=O)N(Cc1cccnc1)c1ccc(-c2ccc(F)cc2)cc1F,.,= ,0.47,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
CC(=O)N(Cc1cccnc1)c1ccc(-c2ccc(F)cc2)cc1F,CC(=O)N(Cc1cccnc1)c1ccc(-c2ccc(F)cc2)cc1F,.,= ,2.16,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 3,ORGANISM,14.0,HEOS,,,,
CC(=O)N(Cc1cccnc1)c1ccc(-c2ccc(F)cc2)cc1F,CC(=O)N(Cc1cccnc1)c1ccc(-c2ccc(F)cc2)cc1F,.,= ,30.0,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CC(=O)N(Cc1cccnc1)c1ccc(-c2ccc(F)cc2)cc1F,CC(=O)N(Cc1cccnc1)c1ccc(-c2ccc(F)cc2)cc1F,.,= ,19.16,PBS - pH 6.5,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10,1.0,A,PBS - pH 6.5,NEPH_RT,ORGANISM,14.0,HEOS,,,,
CC(=O)N(Cc1cccnc1)c1ccc(-c2ccc(F)cc2)cc1F,CC(=O)N(Cc1cccnc1)c1ccc(-c2ccc(F)cc2)cc1F,.,= ,65.87,0.01M HCl - pH 2,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10,1.0,A,0.01M HCl - pH 2,NEPH_RT,ORGANISM,14.0,HEOS,,,,
CC(=O)N(Cc1cccnc1)c1ccc(-c2ccc(F)cc2)cc1F,CC(=O)N(Cc1cccnc1)c1ccc(-c2ccc(F)cc2)cc1F,.,= ,3.7,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
CC(=O)N(Cc1cccnc1)c1ccc(-c2ccc(F)cc2)cc1F,CC(=O)N(Cc1cccnc1)c1ccc(-c2ccc(F)cc2)cc1F,.,= ,0.0535,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CC(=O)N(Cc1cccnc1)c1ccc(-c2ccc(F)cc2)cc1F,CC(=O)N(Cc1cccnc1)c1ccc(-c2ccc(F)cc2)cc1F,.,= ,0.598,Human,,,none,,EH,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CC(=O)N(Cc1cccnc1)c1ccc(-c2ccc(F)cc2)cc1F,CC(=O)N(Cc1cccnc1)c1ccc(-c2ccc(F)cc2)cc1F,.,= ,57.8,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)N(Cc1cnc[nH]1)c1ccc(-c2nc3ccccc3s2)cc1,CS(=O)(=O)N(Cc1cnc[nH]1)c1ccc(-c2nc3ccccc3s2)cc1,.,= ,72.0,Rat,,,none,,% bound,In Vitro,,protein binding,set10,1.0,A,Rat,Liver Microsomes,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)N(Cc1cnc[nH]1)c1ccc(-c2nc3ccccc3s2)cc1,CS(=O)(=O)N(Cc1cnc[nH]1)c1ccc(-c2nc3ccccc3s2)cc1,.,= ,100.0,T. cruzi,,,%,,Parasitemia clearance after treatment,In Vivo,,"Chagas in vivo at 20 mg/kg, 20 days 2x",set10,1.0,F,T. cruzi,Tulahuen Swiss po,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)N(Cc1cnc[nH]1)c1ccc(-c2nc3ccccc3s2)cc1,CS(=O)(=O)N(Cc1cnc[nH]1)c1ccc(-c2nc3ccccc3s2)cc1,.,= ,0.0,T. cruzi,,,%,,Parasitemia clearance after immunosuppression,In Vivo,,"Chagas in vivo at 20 mg/kg, 20 days 2x",set10,1.0,F,T. cruzi,Tulahuen Swiss po,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)N(Cc1cnc[nH]1)c1ccc(-c2nc3ccccc3s2)cc1,CS(=O)(=O)N(Cc1cnc[nH]1)c1ccc(-c2nc3ccccc3s2)cc1,.,= ,0.0,T. cruzi,,,%,,PCR cure rate,In Vivo,,"Chagas in vivo at 20 mg/kg, 20 days 2x",set10,1.0,F,T. cruzi,Tulahuen Swiss po,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)N(Cc1cnc[nH]1)c1ccc(-c2nc3ccccc3s2)cc1,CS(=O)(=O)N(Cc1cnc[nH]1)c1ccc(-c2nc3ccccc3s2)cc1,.,= ,0.0039,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)N(Cc1cnc[nH]1)c1ccc(-c2nc3ccccc3s2)cc1,CS(=O)(=O)N(Cc1cnc[nH]1)c1ccc(-c2nc3ccccc3s2)cc1,.,= ,21.92,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)N(Cc1cnc[nH]1)c1ccc(-c2nc3ccccc3s2)cc1,CS(=O)(=O)N(Cc1cnc[nH]1)c1ccc(-c2nc3ccccc3s2)cc1,.,= ,26.95,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)N(Cc1cnc[nH]1)c1ccc(-c2nc3ccccc3s2)cc1,CS(=O)(=O)N(Cc1cnc[nH]1)c1ccc(-c2nc3ccccc3s2)cc1,.,= ,0.00015,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)N(Cc1cnc[nH]1)c1ccc(-c2nc3ccccc3s2)cc1,CS(=O)(=O)N(Cc1cnc[nH]1)c1ccc(-c2nc3ccccc3s2)cc1,.,= ,0.00019,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)N(Cc1cnc[nH]1)c1ccc(-c2nc3ccccc3s2)cc1,CS(=O)(=O)N(Cc1cnc[nH]1)c1ccc(-c2nc3ccccc3s2)cc1,.,= ,0.0039,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)N(Cc1cnc[nH]1)c1ccc(-c2nc3ccccc3s2)cc1,CS(=O)(=O)N(Cc1cnc[nH]1)c1ccc(-c2nc3ccccc3s2)cc1,.,= ,49.97,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)N(Cc1cnc[nH]1)c1ccc(-c2nc3ccccc3s2)cc1,CS(=O)(=O)N(Cc1cnc[nH]1)c1ccc(-c2nc3ccccc3s2)cc1,.,= ,33.57,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)N(Cc1cnc[nH]1)c1ccc(-c2nc3ccccc3s2)cc1,CS(=O)(=O)N(Cc1cnc[nH]1)c1ccc(-c2nc3ccccc3s2)cc1,.,= ,0.00058,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)N(Cc1cnc[nH]1)c1ccc(-c2nc3ccccc3s2)cc1,CS(=O)(=O)N(Cc1cnc[nH]1)c1ccc(-c2nc3ccccc3s2)cc1,.,= ,0.00069,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)N(Cc1cnc[nH]1)c1ccc(-c2nc3ccccc3s2)cc1,CS(=O)(=O)N(Cc1cnc[nH]1)c1ccc(-c2nc3ccccc3s2)cc1,.,= ,0.68,Human,,,none,,EH,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)N(Cc1cnc[nH]1)c1ccc(-c2nc3ccccc3s2)cc1,CS(=O)(=O)N(Cc1cnc[nH]1)c1ccc(-c2nc3ccccc3s2)cc1,.,= ,2.3,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)N(Cc1cnc[nH]1)c1ccc(-c2nc3ccccc3s2)cc1,CS(=O)(=O)N(Cc1cnc[nH]1)c1ccc(-c2nc3ccccc3s2)cc1,.,= ,,PBS - pH 6.5,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10,1.0,A,PBS - pH 6.5,NEPH_RT,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)N(Cc1cnc[nH]1)c1ccc(-c2nc3ccccc3s2)cc1,CS(=O)(=O)N(Cc1cnc[nH]1)c1ccc(-c2nc3ccccc3s2)cc1,.,= ,32.0,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)N(Cc1cnc[nH]1)c1ccc(-c2nc3ccccc3s2)cc1,CS(=O)(=O)N(Cc1cnc[nH]1)c1ccc(-c2nc3ccccc3s2)cc1,.,= ,55.0,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)N(Cc1cnc[nH]1)c1ccc(-c2nc3ccccc3s2)cc1,CS(=O)(=O)N(Cc1cnc[nH]1)c1ccc(-c2nc3ccccc3s2)cc1,.,= ,1.6,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 3,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)N(Cc1cnc[nH]1)c1ccc(-c2nc3ccccc3s2)cc1,CS(=O)(=O)N(Cc1cnc[nH]1)c1ccc(-c2nc3ccccc3s2)cc1,.,= ,1.5,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)N(Cc1cnc[nH]1)c1ccc(-c2nc3ccccc3s2)cc1,CS(=O)(=O)N(Cc1cnc[nH]1)c1ccc(-c2nc3ccccc3s2)cc1,.,= ,0.0001,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)N(Cc1cnc[nH]1)c1ccc(-c2nc3ccccc3s2)cc1,CS(=O)(=O)N(Cc1cnc[nH]1)c1ccc(-c2nc3ccccc3s2)cc1,.,= ,48.0,CYP3A4,,,%,,% inhibition,In Vitro,,CYP Inhibition at 1 uM,set10,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)N(Cc1cnc[nH]1)c1ccc(-c2nc3ccccc3s2)cc1,CS(=O)(=O)N(Cc1cnc[nH]1)c1ccc(-c2nc3ccccc3s2)cc1,.,= ,85.0,CYP3A4,,,%,,% inhibition,In Vitro,,CYP Inhibition at 10 uM,set10,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)N(Cc1cnc[nH]1)c1ccc(-c2nc3ccccc3s2)cc1,CS(=O)(=O)N(Cc1cnc[nH]1)c1ccc(-c2nc3ccccc3s2)cc1,.,= ,50.06,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccn3)s2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccn3)s2)c1,.,= ,1.8,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 3,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccn3)s2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccn3)s2)c1,.,= ,3.0,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccn3)s2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccn3)s2)c1,.,= ,0.00293333333333333,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccn3)s2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccn3)s2)c1,.,= ,42.0,CYP3A4,,,%,,% inhibition,In Vitro,,CYP Inhibition at 1 uM,set10,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccn3)s2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccn3)s2)c1,.,= ,83.0,CYP3A4,,,%,,% inhibition,In Vitro,,CYP Inhibition at 10 uM,set10,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccn3)s2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccn3)s2)c1,.,= ,67.98,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccn3)s2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccn3)s2)c1,.,= ,0.01936666666666666,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccn3)s2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccn3)s2)c1,.,= ,75.0,Mouse,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10,1.0,A,Mouse,Microsomes,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccn3)s2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccn3)s2)c1,.,= ,0.62,Mouse,,,none,,EH,In Vitro,,Metabolism,set10,1.0,A,Mouse,Microsomes,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccn3)s2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccn3)s2)c1,.,= ,23.0,Mouse,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10,1.0,A,Mouse,Microsomes,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccn3)s2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccn3)s2)c1,.,= ,0.0055,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccn3)s2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccn3)s2)c1,.,= ,0.017,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccn3)s2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccn3)s2)c1,.,= ,20.0,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccn3)s2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccn3)s2)c1,.,= ,85.0,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccn3)s2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccn3)s2)c1,.,= ,6.3,PBS - pH 6.5,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10,1.0,A,PBS - pH 6.5,NEPH_RT,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccn3)s2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccn3)s2)c1,.,= ,2.7,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccn3)s2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccn3)s2)c1,.,= ,0.44,Human,,,none,,EH,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,.,= ,0.151,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,.,= ,49.0,CYP3A4,,,%,,% inhibition,In Vitro,,CYP Inhibition at 10 uM,set10,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,.,= ,0.023,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,.,= ,1.6,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 3,ORGANISM,14.0,HEOS,,,,
Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,.,= ,93.0,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,.,= ,19.0,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,.,= ,,PBS - pH 6.5,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10,1.0,A,PBS - pH 6.5,NEPH_RT,ORGANISM,14.0,HEOS,,,,
Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,.,= ,2.7,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,.,= ,0.78,Human,,,none,,EH,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,.,= ,15.0,CYP3A4,,,%,,% inhibition,In Vitro,,CYP Inhibition at 1 uM,set10,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)cn2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)cn2)c1,.,= ,3.9,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)cn2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)cn2)c1,.,= ,25.0,0.01M HCl - pH 2,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10,1.0,A,0.01M HCl - pH 2,NEPH_RT,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)cn2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)cn2)c1,.,= ,58.0,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)cn2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)cn2)c1,.,= ,29.0,Mouse,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10,1.0,A,Mouse,Microsomes,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)cn2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)cn2)c1,.,= ,30.0,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)cn2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)cn2)c1,.,= ,0.38,Mouse,,,none,,EH,In Vitro,,Metabolism,set10,1.0,A,Mouse,Microsomes,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)cn2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)cn2)c1,.,= ,61.0,Mouse,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10,1.0,A,Mouse,Microsomes,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)cn2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)cn2)c1,.,= ,66.0,Rat,,,none,,% bound,In Vitro,,protein binding,set10,1.0,A,Rat,Liver Microsomes,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)cn2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)cn2)c1,.,= ,32.3,Rat,,,mL/min/kg,,CLblood,In Vitro,,Metabolism,set10,1.0,A,Rat,Hepatocytes,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)cn2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)cn2)c1,.,= ,38.0,Rat,,,mL/min/kg,,CLblood,In Vitro,,Metabolism,set10,1.0,A,Rat,Microsomes,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)cn2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)cn2)c1,.,= ,0.0089,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)cn2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)cn2)c1,.,= ,58.68,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)cn2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)cn2)c1,.,= ,55.0,CYP3A4,,,%,,% inhibition,In Vitro,,CYP Inhibition at 10 uM,set10,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)cn2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)cn2)c1,.,= ,29.0,CYP3A4,,,%,,% inhibition,In Vitro,,CYP Inhibition at 1 uM,set10,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)cn2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)cn2)c1,.,= ,0.48,Rat,,,none,,EH,In Vitro,,Metabolism,set10,1.0,A,Rat,Hepatocytes,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)cn2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)cn2)c1,.,= ,0.00253333333333333,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)cn2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)cn2)c1,.,= ,8.0,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)cn2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)cn2)c1,.,= ,35.0,Rat,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10,1.0,A,Rat,Microsomes,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)cn2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)cn2)c1,.,= ,2.6,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 3,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)cn2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)cn2)c1,.,= ,50.0,Rat,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10,1.0,A,Rat,Microsomes,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)cn2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)cn2)c1,.,= ,0.56,Rat,,,none,,EH,In Vitro,,Metabolism,set10,1.0,A,Rat,Microsomes,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)cn2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)cn2)c1,.,= ,0.54,Human,,,none,,EH,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,0.81,Human,,,none,,EH,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,3.0,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,,PBS - pH 6.5,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10,1.0,A,PBS - pH 6.5,NEPH_RT,ORGANISM,14.0,HEOS,,,,
Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,16.0,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,109.0,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,1.8,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 3,ORGANISM,14.0,HEOS,,,,
Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,0.001975,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,73.0,CYP3A4,,,%,,% inhibition,In Vitro,,CYP Inhibition at 1 uM,set10,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,93.0,CYP3A4,,,%,,% inhibition,In Vitro,,CYP Inhibition at 10 uM,set10,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,86.64,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,0.015,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CCN(Cc1c[nH]cn1)c1ccc(-c2nc3ccccc3s2)cc1,CCN(Cc1c[nH]cn1)c1ccc(-c2nc3ccccc3s2)cc1,.,= ,3.4,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
CCN(Cc1c[nH]cn1)c1ccc(-c2nc3ccccc3s2)cc1,CCN(Cc1c[nH]cn1)c1ccc(-c2nc3ccccc3s2)cc1,.,= ,3.1,PBS - pH 6.5,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10,1.0,A,PBS - pH 6.5,NEPH_RT,ORGANISM,14.0,HEOS,,,,
CCN(Cc1c[nH]cn1)c1ccc(-c2nc3ccccc3s2)cc1,CCN(Cc1c[nH]cn1)c1ccc(-c2nc3ccccc3s2)cc1,.,= ,2.1,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 3,ORGANISM,14.0,HEOS,,,,
CCN(Cc1c[nH]cn1)c1ccc(-c2nc3ccccc3s2)cc1,CCN(Cc1c[nH]cn1)c1ccc(-c2nc3ccccc3s2)cc1,.,= ,4.0,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
CCN(Cc1c[nH]cn1)c1ccc(-c2nc3ccccc3s2)cc1,CCN(Cc1c[nH]cn1)c1ccc(-c2nc3ccccc3s2)cc1,.,= ,0.01533333333333333,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CCN(Cc1c[nH]cn1)c1ccc(-c2nc3ccccc3s2)cc1,CCN(Cc1c[nH]cn1)c1ccc(-c2nc3ccccc3s2)cc1,.,= ,97.4,Rat,,,none,,% bound,In Vitro,,protein binding,set10,1.0,A,Rat,Liver Microsomes,ORGANISM,14.0,HEOS,,,,
CCN(Cc1c[nH]cn1)c1ccc(-c2nc3ccccc3s2)cc1,CCN(Cc1c[nH]cn1)c1ccc(-c2nc3ccccc3s2)cc1,.,= ,80.0,T. cruzi,,,%,,Parasitemia clearance after treatment,In Vivo,,"Chagas in vivo at 20 mg/kg, 20 days 2x",set10,1.0,F,T. cruzi,Tulahuen Swiss po,ORGANISM,14.0,HEOS,,,,
CCN(Cc1c[nH]cn1)c1ccc(-c2nc3ccccc3s2)cc1,CCN(Cc1c[nH]cn1)c1ccc(-c2nc3ccccc3s2)cc1,.,= ,0.0,T. cruzi,,,%,,Parasitemia clearance after immunosuppression,In Vivo,,"Chagas in vivo at 20 mg/kg, 20 days 2x",set10,1.0,F,T. cruzi,Tulahuen Swiss po,ORGANISM,14.0,HEOS,,,,
CCN(Cc1c[nH]cn1)c1ccc(-c2nc3ccccc3s2)cc1,CCN(Cc1c[nH]cn1)c1ccc(-c2nc3ccccc3s2)cc1,.,= ,0.0,T. cruzi,,,%,,PCR cure rate,In Vivo,,"Chagas in vivo at 20 mg/kg, 20 days 2x",set10,1.0,F,T. cruzi,Tulahuen Swiss po,ORGANISM,14.0,HEOS,,,,
CCN(Cc1c[nH]cn1)c1ccc(-c2nc3ccccc3s2)cc1,CCN(Cc1c[nH]cn1)c1ccc(-c2nc3ccccc3s2)cc1,.,= ,37.0,CYP3A4,,,%,,% inhibition,In Vitro,,CYP Inhibition at 1 uM,set10,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
CCN(Cc1c[nH]cn1)c1ccc(-c2nc3ccccc3s2)cc1,CCN(Cc1c[nH]cn1)c1ccc(-c2nc3ccccc3s2)cc1,.,= ,80.0,CYP3A4,,,%,,% inhibition,In Vitro,,CYP Inhibition at 10 uM,set10,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
CCN(Cc1c[nH]cn1)c1ccc(-c2nc3ccccc3s2)cc1,CCN(Cc1c[nH]cn1)c1ccc(-c2nc3ccccc3s2)cc1,.,= ,35.98,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
CCN(Cc1c[nH]cn1)c1ccc(-c2nc3ccccc3s2)cc1,CCN(Cc1c[nH]cn1)c1ccc(-c2nc3ccccc3s2)cc1,.,= ,0.156,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)N(Cc1cccnc1)c1ccc(-c2ccc(F)cc2)cc1F,CS(=O)(=O)N(Cc1cccnc1)c1ccc(-c2ccc(F)cc2)cc1F,.,= ,217.6,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)N(Cc1cccnc1)c1ccc(-c2ccc(F)cc2)cc1F,CS(=O)(=O)N(Cc1cccnc1)c1ccc(-c2ccc(F)cc2)cc1F,.,= ,1.89,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 3,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)N(Cc1cccnc1)c1ccc(-c2ccc(F)cc2)cc1F,CS(=O)(=O)N(Cc1cccnc1)c1ccc(-c2ccc(F)cc2)cc1F,.,= ,0.612,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)N(Cc1cccnc1)c1ccc(-c2ccc(F)cc2)cc1F,CS(=O)(=O)N(Cc1cccnc1)c1ccc(-c2ccc(F)cc2)cc1F,.,= ,0.002,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)N(Cc1cccnc1)c1ccc(-c2ccc(F)cc2)cc1F,CS(=O)(=O)N(Cc1cccnc1)c1ccc(-c2ccc(F)cc2)cc1F,.,= ,0.001,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)N(Cc1cccnc1)c1ccc(-c2ccc(F)cc2)cc1F,CS(=O)(=O)N(Cc1cccnc1)c1ccc(-c2ccc(F)cc2)cc1F,.,= ,66.39,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)N(Cc1cccnc1)c1ccc(-c2ccc(F)cc2)cc1F,CS(=O)(=O)N(Cc1cccnc1)c1ccc(-c2ccc(F)cc2)cc1F,.,= ,66.46,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)N(Cc1cccnc1)c1ccc(-c2ccc(F)cc2)cc1F,CS(=O)(=O)N(Cc1cccnc1)c1ccc(-c2ccc(F)cc2)cc1F,.,= ,59.43,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)N(Cc1cccnc1)c1ccc(-c2ccc(F)cc2)cc1F,CS(=O)(=O)N(Cc1cccnc1)c1ccc(-c2ccc(F)cc2)cc1F,.,= ,44.29,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)N(Cc1cccnc1)c1ccc(-c2ccc(F)cc2)cc1F,CS(=O)(=O)N(Cc1cccnc1)c1ccc(-c2ccc(F)cc2)cc1F,.,= ,0.0146,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)N(Cc1cccnc1)c1ccc(-c2ccc(F)cc2)cc1F,CS(=O)(=O)N(Cc1cccnc1)c1ccc(-c2ccc(F)cc2)cc1F,.,= ,0.006,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)N(Cc1cccnc1)c1ccc(-c2ccc(F)cc2)cc1F,CS(=O)(=O)N(Cc1cccnc1)c1ccc(-c2ccc(F)cc2)cc1F,.,= ,7.9,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)N(Cc1cccnc1)c1ccc(-c2ccc(F)cc2)cc1F,CS(=O)(=O)N(Cc1cccnc1)c1ccc(-c2ccc(F)cc2)cc1F,.,= ,8.62,PBS - pH 6.5,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10,1.0,A,PBS - pH 6.5,NEPH_RT,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)N(Cc1cccnc1)c1ccc(-c2ccc(F)cc2)cc1F,CS(=O)(=O)N(Cc1cccnc1)c1ccc(-c2ccc(F)cc2)cc1F,.,= ,3.18,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)N(Cc1cccnc1)c1ccc(-c2ccc(F)cc2)cc1F,CS(=O)(=O)N(Cc1cccnc1)c1ccc(-c2ccc(F)cc2)cc1F,.,= ,0.916,Human,,,none,,EH,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CC(=O)N(Cc1c[nH]cn1)c1ccc(-c2nc3ccccc3s2)cc1,CC(=O)N(Cc1c[nH]cn1)c1ccc(-c2nc3ccccc3s2)cc1,.,= ,0.35,Human,,,none,,EH,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CC(=O)N(Cc1c[nH]cn1)c1ccc(-c2nc3ccccc3s2)cc1,CC(=O)N(Cc1c[nH]cn1)c1ccc(-c2nc3ccccc3s2)cc1,.,= ,2.1,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
CC(=O)N(Cc1c[nH]cn1)c1ccc(-c2nc3ccccc3s2)cc1,CC(=O)N(Cc1c[nH]cn1)c1ccc(-c2nc3ccccc3s2)cc1,.,= ,,PBS - pH 6.5,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10,1.0,A,PBS - pH 6.5,NEPH_RT,ORGANISM,14.0,HEOS,,,,
CC(=O)N(Cc1c[nH]cn1)c1ccc(-c2nc3ccccc3s2)cc1,CC(=O)N(Cc1c[nH]cn1)c1ccc(-c2nc3ccccc3s2)cc1,.,= ,123.0,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CC(=O)N(Cc1c[nH]cn1)c1ccc(-c2nc3ccccc3s2)cc1,CC(=O)N(Cc1c[nH]cn1)c1ccc(-c2nc3ccccc3s2)cc1,.,= ,21.0,Mouse,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10,1.0,A,Mouse,Microsomes,ORGANISM,14.0,HEOS,,,,
CC(=O)N(Cc1c[nH]cn1)c1ccc(-c2nc3ccccc3s2)cc1,CC(=O)N(Cc1c[nH]cn1)c1ccc(-c2nc3ccccc3s2)cc1,.,= ,0.32,Mouse,,,none,,EH,In Vitro,,Metabolism,set10,1.0,A,Mouse,Microsomes,ORGANISM,14.0,HEOS,,,,
CC(=O)N(Cc1c[nH]cn1)c1ccc(-c2nc3ccccc3s2)cc1,CC(=O)N(Cc1c[nH]cn1)c1ccc(-c2nc3ccccc3s2)cc1,.,= ,81.0,Mouse,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10,1.0,A,Mouse,Microsomes,ORGANISM,14.0,HEOS,,,,
CC(=O)N(Cc1c[nH]cn1)c1ccc(-c2nc3ccccc3s2)cc1,CC(=O)N(Cc1c[nH]cn1)c1ccc(-c2nc3ccccc3s2)cc1,.,= ,1.6,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 3,ORGANISM,14.0,HEOS,,,,
CC(=O)N(Cc1c[nH]cn1)c1ccc(-c2nc3ccccc3s2)cc1,CC(=O)N(Cc1c[nH]cn1)c1ccc(-c2nc3ccccc3s2)cc1,.,= ,0.0135,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CC(=O)N(Cc1c[nH]cn1)c1ccc(-c2nc3ccccc3s2)cc1,CC(=O)N(Cc1c[nH]cn1)c1ccc(-c2nc3ccccc3s2)cc1,.,= ,0.3,CYP3A4,,,%,,% inhibition,In Vitro,,CYP Inhibition at 1 uM,set10,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
CC(=O)N(Cc1c[nH]cn1)c1ccc(-c2nc3ccccc3s2)cc1,CC(=O)N(Cc1c[nH]cn1)c1ccc(-c2nc3ccccc3s2)cc1,.,= ,28.1,CYP3A4,,,%,,% inhibition,In Vitro,,CYP Inhibition at 10 uM,set10,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
CC(=O)N(Cc1c[nH]cn1)c1ccc(-c2nc3ccccc3s2)cc1,CC(=O)N(Cc1c[nH]cn1)c1ccc(-c2nc3ccccc3s2)cc1,.,= ,63.44,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
CC(=O)N(Cc1c[nH]cn1)c1ccc(-c2nc3ccccc3s2)cc1,CC(=O)N(Cc1c[nH]cn1)c1ccc(-c2nc3ccccc3s2)cc1,.,= ,0.027,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CC(=O)N(Cc1c[nH]cn1)c1ccc(-c2nc3ccccc3s2)cc1,CC(=O)N(Cc1c[nH]cn1)c1ccc(-c2nc3ccccc3s2)cc1,.,= ,14.0,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CCN(Cc1cnc[nH]1)c1cc(F)cc(-c2nc3ccccc3s2)c1,CCN(Cc1cnc[nH]1)c1cc(F)cc(-c2nc3ccccc3s2)c1,.,= ,0.874,Human,,,none,,EH,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CCN(Cc1cnc[nH]1)c1cc(F)cc(-c2nc3ccccc3s2)c1,CCN(Cc1cnc[nH]1)c1cc(F)cc(-c2nc3ccccc3s2)c1,.,= ,4.67,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
CCN(Cc1cnc[nH]1)c1cc(F)cc(-c2nc3ccccc3s2)c1,CCN(Cc1cnc[nH]1)c1cc(F)cc(-c2nc3ccccc3s2)c1,.,= ,3.1,PBS - pH 6.5,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10,1.0,A,PBS - pH 6.5,NEPH_RT,ORGANISM,14.0,HEOS,,,,
CCN(Cc1cnc[nH]1)c1cc(F)cc(-c2nc3ccccc3s2)c1,CCN(Cc1cnc[nH]1)c1cc(F)cc(-c2nc3ccccc3s2)c1,.,= ,12.4,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CCN(Cc1cnc[nH]1)c1cc(F)cc(-c2nc3ccccc3s2)c1,CCN(Cc1cnc[nH]1)c1cc(F)cc(-c2nc3ccccc3s2)c1,.,= ,138.4,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CCN(Cc1cnc[nH]1)c1cc(F)cc(-c2nc3ccccc3s2)c1,CCN(Cc1cnc[nH]1)c1cc(F)cc(-c2nc3ccccc3s2)c1,.,= ,1.98,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 3,ORGANISM,14.0,HEOS,,,,
CCN(Cc1cnc[nH]1)c1cc(F)cc(-c2nc3ccccc3s2)c1,CCN(Cc1cnc[nH]1)c1cc(F)cc(-c2nc3ccccc3s2)c1,.,= ,0.576,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
CCN(Cc1cnc[nH]1)c1cc(F)cc(-c2nc3ccccc3s2)c1,CCN(Cc1cnc[nH]1)c1cc(F)cc(-c2nc3ccccc3s2)c1,.,= ,0.051,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CCN(Cc1cnc[nH]1)c1cc(F)cc(-c2nc3ccccc3s2)c1,CCN(Cc1cnc[nH]1)c1cc(F)cc(-c2nc3ccccc3s2)c1,.,= ,0.048,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CCN(Cc1cnc[nH]1)c1cc(F)cc(-c2nc3ccccc3s2)c1,CCN(Cc1cnc[nH]1)c1cc(F)cc(-c2nc3ccccc3s2)c1,.,= ,54.21,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
CCN(Cc1cnc[nH]1)c1cc(F)cc(-c2nc3ccccc3s2)c1,CCN(Cc1cnc[nH]1)c1cc(F)cc(-c2nc3ccccc3s2)c1,.,= ,26.74,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
CCN(Cc1cnc[nH]1)c1cc(F)cc(-c2nc3ccccc3s2)c1,CCN(Cc1cnc[nH]1)c1cc(F)cc(-c2nc3ccccc3s2)c1,.,= ,50.29,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
CCN(Cc1cnc[nH]1)c1cc(F)cc(-c2nc3ccccc3s2)c1,CCN(Cc1cnc[nH]1)c1cc(F)cc(-c2nc3ccccc3s2)c1,.,= ,0.051,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CCN(Cc1cnc[nH]1)c1cc(F)cc(-c2nc3ccccc3s2)c1,CCN(Cc1cnc[nH]1)c1cc(F)cc(-c2nc3ccccc3s2)c1,.,= ,0.11,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
NCC(=O)N(Cc1cccnc1)c1ccc(-c2nc3ccccc3s2)cc1,NCC(=O)N(Cc1cccnc1)c1ccc(-c2nc3ccccc3s2)cc1,.,= ,247.0,Mouse,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10,1.0,A,Mouse,Microsomes,ORGANISM,14.0,HEOS,,,,
NCC(=O)N(Cc1cccnc1)c1ccc(-c2nc3ccccc3s2)cc1,NCC(=O)N(Cc1cccnc1)c1ccc(-c2nc3ccccc3s2)cc1,.,= ,38.0,Rat,,,mL/min/kg,,CLblood,In Vitro,,Metabolism,set10,1.0,A,Rat,Hepatocytes,ORGANISM,14.0,HEOS,,,,
NCC(=O)N(Cc1cccnc1)c1ccc(-c2nc3ccccc3s2)cc1,NCC(=O)N(Cc1cccnc1)c1ccc(-c2nc3ccccc3s2)cc1,.,= ,0.064,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
NCC(=O)N(Cc1cccnc1)c1ccc(-c2nc3ccccc3s2)cc1,NCC(=O)N(Cc1cccnc1)c1ccc(-c2nc3ccccc3s2)cc1,.,= ,0.625,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
NCC(=O)N(Cc1cccnc1)c1ccc(-c2nc3ccccc3s2)cc1,NCC(=O)N(Cc1cccnc1)c1ccc(-c2nc3ccccc3s2)cc1,.,= ,15.43,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
NCC(=O)N(Cc1cccnc1)c1ccc(-c2nc3ccccc3s2)cc1,NCC(=O)N(Cc1cccnc1)c1ccc(-c2nc3ccccc3s2)cc1,.,= ,22.39,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
NCC(=O)N(Cc1cccnc1)c1ccc(-c2nc3ccccc3s2)cc1,NCC(=O)N(Cc1cccnc1)c1ccc(-c2nc3ccccc3s2)cc1,.,= ,58.21,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
NCC(=O)N(Cc1cccnc1)c1ccc(-c2nc3ccccc3s2)cc1,NCC(=O)N(Cc1cccnc1)c1ccc(-c2nc3ccccc3s2)cc1,.,= ,57.24,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
NCC(=O)N(Cc1cccnc1)c1ccc(-c2nc3ccccc3s2)cc1,NCC(=O)N(Cc1cccnc1)c1ccc(-c2nc3ccccc3s2)cc1,.,= ,0.574,Human,,,none,,EH,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
NCC(=O)N(Cc1cccnc1)c1ccc(-c2nc3ccccc3s2)cc1,NCC(=O)N(Cc1cccnc1)c1ccc(-c2nc3ccccc3s2)cc1,.,= ,0.62,Rat,,,none,,EH,In Vitro,,Metabolism,set10,1.0,A,Rat,Microsomes,ORGANISM,14.0,HEOS,,,,
NCC(=O)N(Cc1cccnc1)c1ccc(-c2nc3ccccc3s2)cc1,NCC(=O)N(Cc1cccnc1)c1ccc(-c2nc3ccccc3s2)cc1,.,= ,2.21,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
NCC(=O)N(Cc1cccnc1)c1ccc(-c2nc3ccccc3s2)cc1,NCC(=O)N(Cc1cccnc1)c1ccc(-c2nc3ccccc3s2)cc1,.,= ,63.6,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
NCC(=O)N(Cc1cccnc1)c1ccc(-c2nc3ccccc3s2)cc1,NCC(=O)N(Cc1cccnc1)c1ccc(-c2nc3ccccc3s2)cc1,.,= ,7.0,Mouse,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10,1.0,A,Mouse,Microsomes,ORGANISM,14.0,HEOS,,,,
NCC(=O)N(Cc1cccnc1)c1ccc(-c2nc3ccccc3s2)cc1,NCC(=O)N(Cc1cccnc1)c1ccc(-c2nc3ccccc3s2)cc1,.,= ,27.0,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
NCC(=O)N(Cc1cccnc1)c1ccc(-c2nc3ccccc3s2)cc1,NCC(=O)N(Cc1cccnc1)c1ccc(-c2nc3ccccc3s2)cc1,.,= ,0.24,Mouse,,,none,,EH,In Vitro,,Metabolism,set10,1.0,A,Mouse,Microsomes,ORGANISM,14.0,HEOS,,,,
NCC(=O)N(Cc1cccnc1)c1ccc(-c2nc3ccccc3s2)cc1,NCC(=O)N(Cc1cccnc1)c1ccc(-c2nc3ccccc3s2)cc1,.,= ,0.56,Rat,,,none,,EH,In Vitro,,Metabolism,set10,1.0,A,Rat,Hepatocytes,ORGANISM,14.0,HEOS,,,,
NCC(=O)N(Cc1cccnc1)c1ccc(-c2nc3ccccc3s2)cc1,NCC(=O)N(Cc1cccnc1)c1ccc(-c2nc3ccccc3s2)cc1,.,= ,-0.83,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 3,ORGANISM,14.0,HEOS,,,,
NCC(=O)N(Cc1cccnc1)c1ccc(-c2nc3ccccc3s2)cc1,NCC(=O)N(Cc1cccnc1)c1ccc(-c2nc3ccccc3s2)cc1,.,= ,50.0,Rat,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10,1.0,A,Rat,Microsomes,ORGANISM,14.0,HEOS,,,,
NCC(=O)N(Cc1cccnc1)c1ccc(-c2nc3ccccc3s2)cc1,NCC(=O)N(Cc1cccnc1)c1ccc(-c2nc3ccccc3s2)cc1,.,= ,35.0,Rat,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10,1.0,A,Rat,Microsomes,ORGANISM,14.0,HEOS,,,,
NCC(=O)N(Cc1cccnc1)c1ccc(-c2nc3ccccc3s2)cc1,NCC(=O)N(Cc1cccnc1)c1ccc(-c2nc3ccccc3s2)cc1,.,= ,13.04,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
NCC(=O)N(Cc1cccnc1)c1ccc(-c2nc3ccccc3s2)cc1,NCC(=O)N(Cc1cccnc1)c1ccc(-c2nc3ccccc3s2)cc1,.,= ,0.017,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)N(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,CS(=O)(=O)N(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,.,= ,0.0022,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)N(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,CS(=O)(=O)N(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,.,= ,1.6,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 3,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)N(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,CS(=O)(=O)N(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,.,= ,28.0,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)N(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,CS(=O)(=O)N(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,.,= ,61.0,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)N(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,CS(=O)(=O)N(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,.,= ,,PBS - pH 6.5,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10,1.0,A,PBS - pH 6.5,NEPH_RT,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)N(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,CS(=O)(=O)N(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,.,= ,2.3,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)N(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,CS(=O)(=O)N(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,.,= ,0.52,Human,,,none,,EH,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)N(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,CS(=O)(=O)N(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,.,= ,0.0026,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)N(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,CS(=O)(=O)N(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,.,= ,51.6,CYP3A4,,,%,,% inhibition,In Vitro,,CYP Inhibition at 1 uM,set10,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)N(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,CS(=O)(=O)N(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,.,= ,86.1,CYP3A4,,,%,,% inhibition,In Vitro,,CYP Inhibition at 10 uM,set10,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)N(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,CS(=O)(=O)N(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,.,= ,63.12,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)N(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,CS(=O)(=O)N(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,.,= ,60.65,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)N(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,CS(=O)(=O)N(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,.,= ,67.19,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)N(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,CS(=O)(=O)N(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,.,= ,83.77,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)N(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,CS(=O)(=O)N(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,.,= ,0.0084,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)N(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,CS(=O)(=O)N(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,.,= ,0.0091,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CC(=O)N(Cc1cnc[nH]1)c1cc(F)cc(-c2nc3ccccc3s2)c1.O=CO,CC(=O)N(Cc1cnc[nH]1)c1cc(F)cc(-c2nc3ccccc3s2)c1,O=CO,= ,0.486,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CC(=O)N(Cc1cnc[nH]1)c1cc(F)cc(-c2nc3ccccc3s2)c1.O=CO,CC(=O)N(Cc1cnc[nH]1)c1cc(F)cc(-c2nc3ccccc3s2)c1,O=CO,= ,0.534,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CC(=O)N(Cc1cnc[nH]1)c1cc(F)cc(-c2nc3ccccc3s2)c1.O=CO,CC(=O)N(Cc1cnc[nH]1)c1cc(F)cc(-c2nc3ccccc3s2)c1,O=CO,= ,84.93,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
CC(=O)N(Cc1cnc[nH]1)c1cc(F)cc(-c2nc3ccccc3s2)c1.O=CO,CC(=O)N(Cc1cnc[nH]1)c1cc(F)cc(-c2nc3ccccc3s2)c1,O=CO,= ,98.12,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
CC(=O)N(Cc1cnc[nH]1)c1cc(F)cc(-c2nc3ccccc3s2)c1.O=CO,CC(=O)N(Cc1cnc[nH]1)c1cc(F)cc(-c2nc3ccccc3s2)c1,O=CO,= ,65.13,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
CC(=O)N(Cc1cnc[nH]1)c1cc(F)cc(-c2nc3ccccc3s2)c1.O=CO,CC(=O)N(Cc1cnc[nH]1)c1cc(F)cc(-c2nc3ccccc3s2)c1,O=CO,= ,73.72,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
CC(=O)N(Cc1cnc[nH]1)c1cc(F)cc(-c2nc3ccccc3s2)c1.O=CO,CC(=O)N(Cc1cnc[nH]1)c1cc(F)cc(-c2nc3ccccc3s2)c1,O=CO,= ,0.941,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CC(C)Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,CC(C)Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,0.86,Human,,,none,,EH,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CC(C)Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,CC(C)Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,3.9,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
CC(C)Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,CC(C)Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,11.0,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CC(C)Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,CC(C)Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,157.0,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CC(C)Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,CC(C)Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,2.8,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 3,ORGANISM,14.0,HEOS,,,,
CC(C)Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,CC(C)Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,0.00022,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CC(C)Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,CC(C)Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,0.0002,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CC(C)Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,CC(C)Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,0.018,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CC(C)Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,CC(C)Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,0.096,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CC(C)Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,CC(C)Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,0.00041,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CC(C)Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,CC(C)Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,0.0004,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CC(C)Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,CC(C)Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,75.97,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
CC(C)Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,CC(C)Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,34.35,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
CC(C)Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,CC(C)Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,51.24,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
CC(C)Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,CC(C)Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,81.8,CYP3A4,,,%,,% inhibition,In Vitro,,CYP Inhibition at 10 uM,set10,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
CC(C)Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,CC(C)Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,54.3,CYP3A4,,,%,,% inhibition,In Vitro,,CYP Inhibition at 1 uM,set10,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
CC(C)Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,CC(C)Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)s2)c1,.,= ,0.00019,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CCN(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,CCN(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,.,= ,4.0,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
CCN(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,CCN(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,.,= ,0.0052,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CCN(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,CCN(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,.,= ,0.0025,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CCN(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,CCN(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,.,= ,0.0072,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CCN(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,CCN(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,.,= ,0.0088,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CCN(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,CCN(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,.,= ,39.0,CYP3A4,,,%,,% inhibition,In Vitro,,CYP Inhibition at 1 uM,set10,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
CCN(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,CCN(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,.,= ,76.9,CYP3A4,,,%,,% inhibition,In Vitro,,CYP Inhibition at 10 uM,set10,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
CCN(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,CCN(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,.,= ,61.93,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
CCN(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,CCN(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,.,= ,75.85,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
CCN(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,CCN(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,.,= ,57.56,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
CCN(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,CCN(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,.,= ,48.56,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
CCN(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,CCN(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,.,= ,0.011,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CCN(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,CCN(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,.,= ,0.0089,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CCN(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,CCN(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,.,= ,0.07,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CCN(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,CCN(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,.,= ,0.068,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CCN(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,CCN(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,.,= ,3.4,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
CCN(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,CCN(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,.,= ,0.43,Human,,,none,,EH,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CCN(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,CCN(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,.,= ,,PBS - pH 6.5,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10,1.0,A,PBS - pH 6.5,NEPH_RT,ORGANISM,14.0,HEOS,,,,
CCN(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,CCN(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,.,= ,90.0,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CCN(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,CCN(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,.,= ,2.2,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 3,ORGANISM,14.0,HEOS,,,,
CCN(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,CCN(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,.,= ,39.0,Mouse,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10,1.0,A,Mouse,Microsomes,ORGANISM,14.0,HEOS,,,,
CCN(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,CCN(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,.,= ,0.49,Mouse,,,none,,EH,In Vitro,,Metabolism,set10,1.0,A,Mouse,Microsomes,ORGANISM,14.0,HEOS,,,,
CCN(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,CCN(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,.,= ,19.0,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CCN(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,CCN(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,.,= ,45.0,Mouse,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10,1.0,A,Mouse,Microsomes,ORGANISM,14.0,HEOS,,,,
CC(C)Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,CC(C)Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,.,= ,0.0043,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CC(C)Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,CC(C)Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,.,= ,0.00033,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CC(C)Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,CC(C)Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,.,= ,0.00043,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CC(C)Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,CC(C)Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,.,= ,0.00085,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CC(C)Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,CC(C)Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,.,= ,37.68,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
CC(C)Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,CC(C)Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,.,= ,49.32,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
CC(C)Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,CC(C)Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,.,= ,60.62,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
CC(C)Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,CC(C)Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,.,= ,60.79,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
CC(C)Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,CC(C)Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,.,= ,0.0092,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CC(C)Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,CC(C)Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,.,= ,0.0034,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CC(C)Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,CC(C)Cc1ccc(-n2ccnc2)c(NC(=O)c2cnc(-c3ccccc3)nc2)c1,.,= ,0.0064,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CC(=O)N(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,CC(=O)N(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,.,= ,69.89,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
CC(=O)N(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,CC(=O)N(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,.,= ,0.081,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CC(=O)N(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,CC(=O)N(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,.,= ,0.00031,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CC(=O)N(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,CC(=O)N(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,.,= ,0.035,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CC(=O)N(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,CC(=O)N(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,.,= ,0.0905,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CC(=O)N(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,CC(=O)N(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,.,= ,0.19,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CC(=O)N(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,CC(=O)N(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,.,= ,0.112,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CC(=O)N(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,CC(=O)N(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,.,= ,0.028,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CC(=O)N(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,CC(=O)N(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,.,= ,0.045,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CC(=O)N(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,CC(=O)N(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,.,= ,0.083,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CC(=O)N(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,CC(=O)N(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,.,= ,0.0056,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CC(=O)N(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,CC(=O)N(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,.,= ,0.00026,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CC(=O)N(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,CC(=O)N(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,.,= ,0.034,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CC(=O)N(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,CC(=O)N(Cc1c[nH]cn1)c1ccc(-c2ccc(F)cc2)cc1F,.,= ,0.038,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)N(Cc1cnc[nH]1)c1cc(F)cc(-c2nc3ccccc3s2)c1,CS(=O)(=O)N(Cc1cnc[nH]1)c1cc(F)cc(-c2nc3ccccc3s2)c1,.,= ,0.615,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)N(Cc1cnc[nH]1)c1cc(F)cc(-c2nc3ccccc3s2)c1,CS(=O)(=O)N(Cc1cnc[nH]1)c1cc(F)cc(-c2nc3ccccc3s2)c1,.,= ,0.569,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)N(Cc1cnc[nH]1)c1cc(F)cc(-c2nc3ccccc3s2)c1,CS(=O)(=O)N(Cc1cnc[nH]1)c1cc(F)cc(-c2nc3ccccc3s2)c1,.,= ,66.87,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)N(Cc1cnc[nH]1)c1cc(F)cc(-c2nc3ccccc3s2)c1,CS(=O)(=O)N(Cc1cnc[nH]1)c1cc(F)cc(-c2nc3ccccc3s2)c1,.,= ,63.89,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)N(Cc1cnc[nH]1)c1cc(F)cc(-c2nc3ccccc3s2)c1,CS(=O)(=O)N(Cc1cnc[nH]1)c1cc(F)cc(-c2nc3ccccc3s2)c1,.,= ,0.07,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)N(Cc1cnc[nH]1)c1cc(F)cc(-c2nc3ccccc3s2)c1,CS(=O)(=O)N(Cc1cnc[nH]1)c1cc(F)cc(-c2nc3ccccc3s2)c1,.,= ,0.065,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)N(Cc1cnc[nH]1)c1cc(F)cc(-c2nc3ccccc3s2)c1,CS(=O)(=O)N(Cc1cnc[nH]1)c1cc(F)cc(-c2nc3ccccc3s2)c1,.,= ,0.074,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cncc(-c3ccccc3)n2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cncc(-c3ccccc3)n2)c1,.,= ,2.8,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 3,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cncc(-c3ccccc3)n2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cncc(-c3ccccc3)n2)c1,.,= ,0.769,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cncc(-c3ccccc3)n2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cncc(-c3ccccc3)n2)c1,.,= ,0.639,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cncc(-c3ccccc3)n2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cncc(-c3ccccc3)n2)c1,.,= ,4.16,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cncc(-c3ccccc3)n2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cncc(-c3ccccc3)n2)c1,.,= ,6.36,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cncc(-c3ccccc3)n2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cncc(-c3ccccc3)n2)c1,.,= ,91.9,CYP3A4,,,%,,% inhibition,In Vitro,,CYP Inhibition at 10 uM,set10,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cncc(-c3ccccc3)n2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cncc(-c3ccccc3)n2)c1,.,= ,75.9,CYP3A4,,,%,,% inhibition,In Vitro,,CYP Inhibition at 1 uM,set10,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cncc(-c3ccccc3)n2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cncc(-c3ccccc3)n2)c1,.,= ,0.0062,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cncc(-c3ccccc3)n2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cncc(-c3ccccc3)n2)c1,.,= ,0.0053,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cncc(-c3ccccc3)n2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cncc(-c3ccccc3)n2)c1,.,= ,117.0,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cncc(-c3ccccc3)n2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cncc(-c3ccccc3)n2)c1,.,= ,15.0,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cncc(-c3ccccc3)n2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cncc(-c3ccccc3)n2)c1,.,= ,3.1,PBS - pH 6.5,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10,1.0,A,PBS - pH 6.5,NEPH_RT,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cncc(-c3ccccc3)n2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cncc(-c3ccccc3)n2)c1,.,= ,3.7,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cncc(-c3ccccc3)n2)c1,CO/N=C(\C)c1ccc(-n2ccnc2)c(NC(=O)c2cncc(-c3ccccc3)n2)c1,.,= ,0.82,Human,,,none,,EH,In Vitro,,Metabolism,set10,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
Cl.NCC(=O)N(Cc1cccnc1)c1ccc(-c2nc3ccccc3s2)cc1,NCC(=O)N(Cc1cccnc1)c1ccc(-c2nc3ccccc3s2)cc1,Cl,= ,20.0,T. cruzi,,,%,,PCR cure rate,In Vivo,,"Chagas in vivo at 20 mg/kg, 20 days 2x",set10,1.0,F,T. cruzi,Tulahuen Swiss po,ORGANISM,14.0,HEOS,,,,
Cl.NCC(=O)N(Cc1cccnc1)c1ccc(-c2nc3ccccc3s2)cc1,NCC(=O)N(Cc1cccnc1)c1ccc(-c2nc3ccccc3s2)cc1,Cl,= ,40.0,T. cruzi,,,%,,Parasitemia clearance after immunosuppression,In Vivo,,"Chagas in vivo at 20 mg/kg, 20 days 2x",set10,1.0,F,T. cruzi,Tulahuen Swiss po,ORGANISM,14.0,HEOS,,,,
Cl.NCC(=O)N(Cc1cccnc1)c1ccc(-c2nc3ccccc3s2)cc1,NCC(=O)N(Cc1cccnc1)c1ccc(-c2nc3ccccc3s2)cc1,Cl,= ,100.0,T. cruzi,,,%,,Parasitemia clearance after treatment,In Vivo,,"Chagas in vivo at 20 mg/kg, 20 days 2x",set10,1.0,F,T. cruzi,Tulahuen Swiss po,ORGANISM,14.0,HEOS,,,,
Cl.NCC(=O)N(Cc1cccnc1)c1ccc(-c2nc3ccccc3s2)cc1,NCC(=O)N(Cc1cccnc1)c1ccc(-c2nc3ccccc3s2)cc1,Cl,= ,56.6,Rat,,,none,,% bound,In Vitro,,protein binding,set10,1.0,A,Rat,Liver Microsomes,ORGANISM,14.0,HEOS,,,,
